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ABSTRACT 
Hypoplastic left heart syndrome (HLHS) is a congenital heart defect in which the 
left ventricle is severely underdeveloped. The Norwood procedure is the first stage 
procedure to make an unrestrictive systemic blood flow and at the same time balance it 
with the pulmonary flow. This is done by constructing a neo-aorta using the pulmonary 
artery root and the autologous aorta, and then installing a shunt to the pulmonary artery. 
Variations of the Norwood surgery include the modified Blalock-Taussig (mBT) shunt, 
which diverts blood from the innominate artery to the pulmonary artery (PA), and the 
Right Ventricle Shunt (RVS), which diverts blood from the right ventricle to the PA.  
Recurrent neo-aortic coarctation (NAO) is a frequent complication of the 
Norwood procedure. It causes changes in circulation flow rate balances and hypertension 
in the aortic arch. Conventionally, the value of a coarctation index (CoI) is used in 
choosing interventions to treat NAO. Aortic arch morphology of Norwood patients is 
suspected to be a factor of hemodynamic response to NAO. 
This study aims to develop and validate an in vitro model of the Norwood 
circulation and to use it to better understand the hemodynamic impact of progressive 
coarctation severity in the Norwood patients with mBT and RVS shunts. Five patient-
specific cases were selected, each case having a different aortic morphology. 
 A multi-scale mock circulatory system (MCS) was developed to simulate patient-
specific Norwood circulation. The MCS couples a lumped parameter network (LPN) 
model of the circulation with the 3D test section of the aorta and superior arteries. The 
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system includes branches for the pulmonary, upper body, lower body and single ventricle. 
The MCS was set to patient specific conditions based on the clinical measurements. Flow 
rate and pressure measurements were made around the circulation model. The native arch 
anatomy of each patient was morphed to simulate coarctation by controlling the amount 
of narrowing of the aortic isthmus, while keeping the original patient-specific aortic 
geometry intact. Separate NAO models were created to provide for a range of CoI. Aortic 
pressure measurements were made to study pressure drop and recovery effects. In a 
further study, the MCS was modified to simulate the Norwood circulation with RVS. The 
NAO models were used to study coarctation effects.  
The MCS was validated against clinical measurements. The experimental 
measurements demonstrated that the time-based flow rate and pressure developed within 
the circulation recapitulated clinical measurements (0.72 < R2 < 0.95). The results 
showed good fidelity in replicating the mean values of the Norwood circulation at the 
patient-specific level (p > 0.10).  
The system demonstrated the coarctation effects in the Norwood circulation with 
mBT. For all patient cases, the single ventricle power (SVP), mean pressure difference, 
and Qp/Qs increased noticeably when CoI < 0.5 (p<0.05). An increased SVP correlated 
with abnormal aortic arch morphology (dilated or tubular). 
Measurements from two of four cases studied showed that substituting the mBT 
with the RVS can relieve pulmonary overcirculation and improve the pulmonary to 
systemic flow balance (Qp/Qs). Using the RVS reduced SVP requirements by 74.5 mW 
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on average. A tubular arch morphology was associated with a higher SVP with the RVS 
than those patients with a dilated arch.  
The study has shown that the hypothesis, “NAO may not need immediate surgical 
intervention at an early stage for some patients” was accepted. Aortic arch morphology 
does affect the hemodynamic response to NAO. Any morphological abnormality causes 
extra SVP. The RVS can relieve overcirculation and is associated with lower SVP level 
and SVP changes in some of the patients.  
v 
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 INTRODUCTION: STAGE 1 PALLIATION FOR THE SINGLE VENTRICLE 
HEART DISEASE 
Introduction 
The human heart has four chambers. The upper chambers are called atria, 
while the lower chambers are called ventricles. Atria receive blood flowing into the 
heart, and then ventricles pump blood out of the heart. Specifically, the left ventricle 
pumps oxygenated blood to the aorta, the large artery that carries blood to the body, 
while the right ventricle pumps blood to the pulmonary artery, to exchange CO2 for 
oxygen in the lungs. 
Figure 1.1 Normal Heart anatomy versus HLHS heart anatomy (The Children's 
Hospital of Philadelphia, n.d.) . 
A child with a single ventricle defect is born with a heart with only one 
ventricle that is large enough or strong enough to pump effectively. Hypoplastic left 
heart syndrome (HLHS) is a rare congenital heart defect in which the left ventricle of 
the heart is severely underdeveloped, and generally shows severe endocardial 
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fibroelastosis (Norwood, 1981). In a child with HLHS, the mitral valve is usually too 
small or completely closed, the left ventricle is very small, and also the aortic valve is 
small or completely closed. Figure 1.1 illustrates the normal heart anatomy and the 
HLHS heart anatomy. HLHS can be diagnosed in utero and requires surgical 
treatment immediately after birth. 
HLHS is fatal without treatment. However, even with the treatment, the 
mortality is still very high. A study of mortality rates of the Stage 1 Norwood 
procedure between 1996 through 2005 revealed an early mortality rate of 17.1% and a 
two year mortality rate of 40.1% for HLHS patients. (Atallah, 2008) 
Different surgical strategies to treat HLHS have been developed in the last 
decades, however the philosophy of the strategies have been consistent, that is, to 
suppress the venous and oxygenated blood mixing, bypass the underdeveloped 
chamber, convert the two parallel circulations to series with only one functional 
ventricle. (Fontan, 1971)  
While treating the neonatal patient, Norwood et al. analyzed the complications 
and causes of death, finding that pulmonary vascular resistance (PVR) is naturally 
high for neonates because of their immature lungs. Thus a three-staged surgical 




Figure 1.2. Staged repair for HLHS, left upper picture illustrates a Norwood 
Procedure with mBT shunt, the right upper figure illustrates a Bidirectional Glenn 
procedure with shunt removed, lower figures illustrates a Fontan procedure. 
(Philiadephia, n.d.) 
The three stages of surgeries are typically performed in the first few years of 
patients’ lives, depending on their growth rates. Figure 1.2 presents the post-operative 
heart anatomy of the three surgical stages respectively. The stage 1 surgery usually 
takes place within a few days of birth. The goal of stage 1 surgery is to make an 
unrestrictive systemic blood flow, and at the same time balance the pulmonary flow 
or, specifically, balance the Qp/Qs ratio. Referring to Figure 1.2, this can be achieved 
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by constructing a neo-aorta using the pulmonary artery root and the autologous aorta, 
and then installing a shunt to the pulmonary artery (Norwood procedure). 
Alternatively, banding the pulmonary artery and stenting the descending aorta may be 
considered, depending on the condition of the  patient (Norwood, 1981). The 
volumetric load on the single ventricle is doubled, and oxygenated blood from the 
lungs mixes with the deoxygenated blood of the systemic venous return. 
The stage 2 surgery is usually performed about six months after stage 1, when 
the lungs are sufficiently developed, reducing PVR. The goal of stage 2 is to reduce 
the mixing of oxygenated and deoxygenated blood by diverting only the venous 
return from the upper body to the lungs (Glenn, 1965). In the stage 2 surgery, 
referring to the upper right subfigure in Figure 2, the shunt is removed and the 
superior vena cava is attached to the pulmonary artery directly through the Glenn 
connection, so only deoxygenated blood from the lower body enters the atrium. 
Removing the shunt also restores the volumetric load on the single ventricle to a 
natural value. 
The stage 3 surgery is usually performed at about 18 to 36 months after stage 
2. By that time, the lower body portion of systemic blood flow has increased, and the 
lungs are mature enough that the PVR is low, requiring less pressure to drive 
pulmonary flow. The goal of stage 3 surgery is to stop the mixing of oxygenated and 
deoxygenated blood by diverting the lower body systemic venous return directly to 
the lungs. Referring to the lower subfigure of Figure 2, the inferior vena cava is 
surgically connected to the pulmonary artery, directing the deoxygenated blood to the 
lungs. Then, all deoxygenated blood flows passively through the lungs (Fontan, 1971). 
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In essence the circulation path has been restored to a normal serial path, but without 
the benefit of the right ventricle.  
The stage 1 surgery  
The purpose of the stage 1 surgery is to create an unrestrictive systemic blood 
flow and, at the same time, attempt to balance the pulmonary flow with the systemic 
flow, the Qp/Qs ratio.  
Through the past decades, the most prevalent way to achieve these goals is the 
Norwood procedure. The main pulmonary (aorta?) artery is dissected from the 
pulmonary artery root. The root is used to reconstruct a neoaorta, and then a 
cardiopulmonary shunt is created to connect the aorta to the main pulmonary artery. 
The shunt diameter is designed to provide the correct pulmonary blood flow, 
balanced with the systemic flow. Figure 1.3 illustrates the procedure’s outcome, 
creating parallel pulmonary and systemic circulations (Pennati, 2010). Systemic 
vascular resistance (SVR) and pulmonary vascular resistance (PVR) must be carefully 
manipulated to achieve a balanced circulation with adequate systemic oxygen 
delivery. Since both the systemic and pulmonary circulation are supplied by the 
single ventricle, the relative distribution of blood flow to the systemic and pulmonary 




Figure 1.3. Comparison of (a) normal circulation and (b) stage 1 reconstructed 
parallel systemic and pulmonary circulation. RV= Right ventricle, LV = left ventricle, 
PC= pulmonary circulation, SC= systemic circulation, SPAS= systemic to pulmonary 
artery shunt. (Pennati, 2010)   
There are several variations of the stage 1 surgery. Figure 1.4 illustrates the 
most prevalent configurations for the placement of the shunt in the stage 1 surgery. 
(Pennati, 2010) (Tomoyasu, 2009). 
    
Figure 1.4. Variations in stage 1 procedure, BT denotes a BT shunt, mBT denotes an 
mBT shunt, RVS denotes a right ventricle shunt and WS denotes a Waterson shunt or 
central shunt, and bPAB denotes bilateral Pulmonary Artery Banding. (Pennati, 2010)   
The BT shunt, initially reported in 1945 to treat tetralogy of Fallot, was named 
after its developers Blalock and Taussig. As shown in Figure 1.4 (left), the original 
procedure proposed was to cut one branch of the subclavian artery or carotid 





(Blalock, 1945). However, the drawback of the BT shunt is that the cut artery 
completely interrupts some blood supply to the upper body. With the introduction of 
polytetrafluoroethylene (PTFE) as a biomaterial into practice, the modified BT shunt 
(mBT shunt) technique was developed. Illustrated in Figure 1.4 (second left), a non-
valved shunt made of PTFE is sewn into place between either the subclavian or the 
carotid artery, and the corresponding side branch of the pulmonary artery (Moulton, 
1985).  The mBT shunt physiology is characterized by high pulse pressure and 
diastolic runoff.  This reduces diastolic coronary circulation, and is implicated in 
blood “stealing” from the systemic arteries, especially the individual artery to which 
the shunt is attached. 
A Waterson shunt (WS) (second right in Figure 1.4), or Central shunt, was 
reported in 1961 as an approach to treat tetralogy of Fallot (Waterson, 1961). The WS 
is composed of a conduit installed between the ascending aorta and the main 
pulmonary artery as shown in Figure 1.4 (second from right), thus resulting in a more 
balanced flow distribution between the two pulmonary arteries. It is also considered 
as an alternative for a neonate with a small subclavian artery.  
A right ventricle shunt (RVS), also known as a Sano shunt, is constructed with 
a PTFE non-valved conduit between the right ventricle and the right pulmonary artery, 
as shown in Figure 1.4 (center). Compared with the mBT shunt, the RVS is usually 
larger in diameter. It provides a more pulsatile pulmonary blood flow and, at the same 
time, a less pulsatile systemic blood flow with less diastolic pressure runoff. It 
obviates the reduced diastolic blood flow in the coronary circulation associated with 
the mBT shunt. (Sano, 2003) The concept was first presented by Norwood et al. 
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Norwood et al described it as “placement of valved or non-valved conduit from the 
right ventricular outflow tract to the distal main pulmonary” (Norwood, 1981).  
Bilateral Pulmonary Artery Banding (bPAB) is another option for Stage 1 
Surgery. bPAB was first proposed by Muller et al in 1952 as a successful case report 
(Muller, 1952). The goal of bPAB is to reduce the pulmonary artery pressure and 
excess pulmonary blood flow. As illustrated in Figure 1.4 (right), the surgical 
technique to achieve this is to install a band around the one or both sides of the 
pulmonary artery to reduce blood flow into the lungs, preventing pulmonary over-
circulation, thus regulating the balance of Qp/Qs. The limitation of this technique is 
that resistance of the banded location is very sensitive to the tightness of the band, so 
it is very difficult to achieve the optimal tightness, thus to achieve the desired balance 
of pressures and flows. It is only applicable where there remains a sufficient aorta to 
provide systemic circulation, or else the ductus arteriosus can be kept patent. 
The advantages of the various stage 1 configurations are always debated 
among surgeons, especially the comparison of the most prevalent RVS and mBT 
shunts. Till today, it is very hard to say which option is better. 
In the 2000s, for the first time, some nonrandomized studies reported some 
short-term advantages of RVS compared with mBT shunts (Ohye, 2007) (Mahle, 
2003) (Mair, 2003) (Sano, 2003), which triggered the interest for more RVS research. 
Among these studies, the most representative one is Sano et al’s study. In Sano’s 
study, significant improvement in both long term and short-term RVS patient survival 
rates compared with mBT patient survival rates was observed. In particular, aortic 
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diastolic runoff into pulmonary circulation was eliminated with RVS. Hence the 
diastolic pressure was restored, systolic hypertension was relieved, and ventricular 
work was reduced. Also worth noting, Sano et al’s study achieved very successful 
results with low weight patients (<2kg), and hemodynamic instabilities never 
occurred in the initial nineteen patients. Sano et al also pointed out that even one 
might argue that the drawback of RVS is that the non-valved shunt allows diastolic 
retrograde flow. Since stage 1 patients are very small and experiencing fast growing, 
it has been observed that the diastolic reverse flow decreased and trans-conduit 
pressure increased in the months after the procedure (Sano, 2003). In a larger clinical 
study, based on a sample of 275 mBT shunts and 274 RVS shunts from 15 clinical 
centers all across America, and using the transplant-free survival at 12 months as the 
criterion, patients with RVS shunts were healthier than patients with mBT shunts.  
On the other hand, one can intuitively argue that RVS is more invasive 
because it requires an incision on the ventricle. Also, a clinical study was conducted 
to compare the interventions after Norwood Procedure using Sano vs. mBT shunt. 
Based on the sample size of 37 Sano shunt and 70 mBT shunt patients, it was found 
that significantly more interventions were required with the Sano shunt, whose 
complications included closure of the femoral or subclavian veins, cerebral embolic 
or bleeding events, and cardiopulmonary resuscitation (Fischbach, 2013).  
Complicated physiological changes also make the Norwood surgery difficult. 
Neonate’s PVR decreases rapidly during the first few months of life due to the 
development of lungs. This phenomenon results in decreased systemic flow rates and 
increased pulmonary flow rate. Eventually these changes can cause unbalanced Qp/Qs 
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in the Norwood circulation. Meanwhile, there is a large variety of native aortic arch 
morphologies and coarctations to be considered. The aortic arch morphology ranges 
from dilated to normal to tubular. Coarctation variation can range from localized 
coarctation to interrupted aortic arch. Additionally, shunt placement and surgical 
anastomosis design are also influential in the final surgical results.  
In light of the aforementioned physiologies and pathologies, it has been 
realized that a multi-scale model of Norwood circulation should be developed to 
further the understanding of the Norwood circulation. The model should be tunable 
over a range of these global parameters, such as PVR and SVR. It should also be able 
to show the effect of geometrical changes, such as aortic coarctation and stenosis. 
Most importantly, it should be a responsive model where effects of physiological 
change on both local and global hemodynamics can be studied.  
In the following paragraphs, a multi-scale patient-specific in vitro model of 
Norwood Circulation is presented to meet the aforementioned requirements. The 
model is a bench-top MCS which can be retuned within a workday. It is flexible to 
change so it can be adapted to research of different purposes. The model will be 
validated against clinical measurement to prove its reliability.  
Aortic coarctation  
Coarctation (COA) is derived from the Latin word ‘Coarctatio’, which means 
crowding or drawing together, fitting closely together, tightening. Coarctation of the 
aorta, or aortic coarctation, was first reported by Morgagni who described such an 
anomaly in an autopsy in 1760 (Morgagni, 1760). Paris was the first to describe the 
full pathological features around 1791 (Paris, 1791). However, the first surgical repair 
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of COA was not reported until 1945 by Crafoord and Nylin (Crafoord, 1945). 
Symptoms of the COA include exercise intolerance, headache, and shortness of 
breath, chest pain, nosebleeds, cold feet, and leg pain after exercise.  
Aortic coarctation is defined as a narrowing of the aortic isthmus, which is 
between the left subclavian artery and the ductus arteriosus. It is different from an 
interrupted aorta, in which the aortic arch has a discontinued aortic wall, while aortic 
coarctation still has a continuous aortic wall (Lee, 2013). The morphology of COA 
can vary widely. The narrowing can be very localized and acute, or it can be very 
gradual and harmonious. This observation was first made by Bonnet when he 
distinguished coarctation into the “adult” type and the “infantile” type, which 
represent localized coarctation and long uniform segment respectively (Bonnet, 1903). 
Edwards et al later described the different types of COA in a more anatomical way. 
Edwards named the long segment of narrowing aortic arch as tubular hypoplasia, 
while the other morphology, a sharp localized stenosis, was defined as coarctation. 
Edwards also explained that it is because of a curtain-like enfolding of the aortic 
media into the lumen of aorta that forms a localized zone of stenosis. Tubular 
hypoplasia, on the other hand, has a normal aortic media (Edwards, 1965) (Edwards, 
1948). Severity of the aortic coarctation is characterized by a non-dimensional 
parameter called Coarctation Index (CoI); it is defined by the diameter ratio of the 





Figure 1.5 Morphologies variations of aortic coarctation, the left subfigure illustrates 
a very tubular aortic coarctation, the narrowing of aortic arch is uniform stretching 
from RSA to DA. The right subfigure illustrates a more localized morphology, aortic 
arch acutely narrows down just past LSA, and then morphs back to normal diameter 
(Da Cruz, 2013). 
  
Each year 0.03% to 0.04% of live newborn infants suffer from COA 
(Hoffman, 2002). COA is represented in 7% of the anomalies in live new born infants 
with congenital heart defects and is more common in males than females (Samanek, 
1999) (Campbell, 1961).  COA is also very prevalent among patients with HLHS, 
occurring in more than 80% of newborns with HLHS. This can be attributed to the 
undeveloped ventricle not supplying sufficient blood to the aorta. The occurrence rate 
of COA between the staged surgeries, or in this case, the recurring neoaortic 
coarctation (NAO), is between 0-37%. NAO, as a frequent complication of Norwood 
Procedure, is one of the major reasons for high morbidity. Recall the key of Norwood 
Procedures is to achieve balanced pulmonary circulation and systemic circulation. 
NAO can cause reduced cardiac output (CO) and reduced descending aorta flow. It 
can also affect the upper body arteries flow and pulmonary shunt flow, upsetting the 
balance of systemic circulation to pulmonary circulation.  
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Whether the COA can be “cured” remains a controversial topic. Due to the 
excellent initial outcome of the repair at the early stage, some regard the result as 
good and permanent. However, others argue that it is clear that those patients go on to 
develop hypertension at early stage of life, which causes devastating consequences 
(Lee, 2013).  
There are various types of techniques to diagnose and repair aortic coarctation 
and tubular hypoplasia, depending on the patient’s condition. Techniques used for 
COA diagnosis include: electrocardiogram (ECG), chest X-ray, echocardiography, 
chest computed tomography (CT or CAT) scan, Magnetic resonance imaging (MRI) 
of the chest, and cardiac catheterization. Among all these technique the most popular 
techniques are echocardiography and cardiac catheterization because these two 
examinations give physicians a direct measure of pressure gradient or pressure 
differential across the coarctation. 
 
Figure 1.6. Pathology specimen demonstrating a section of aortic coarctation. 
(Edwards J. C., 1965) 
There are also a spectrum of choices to treat aortic coarctation, which include 
end-to-end anastomosis (EEA), subclavian flap aorto-plasty (SFA), percutaneous 
balloon angioplasty and expandable endovascular stent. 
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In the HLHS patient, coarctation is normally corrected during stage 1 surgery. 
However, because the neoaorta was reconstructed during stage 1, there is still a very 
high chance, 11%-37%, of recurrent COA, NAO in this case (Go, 2014).  For patients 
who underwent Norwood Procedure, the development of NAO can be lethal (Corsini, 
2012).  
It has long been recognized that COA can cause pressure drop in the lower 
body, increased pressure in the ascending aorta and decreased lower body flow. This 
is because the presence of COA or NAO is equivalent to increased LBSVR. 
Additionally, in Norwood Circulation, the presence of NAO can also disturb shunt 
flow and upper body flow. Severe NAO needs immediate surgical intervention. Mild 
and slight NAO often times does not have significant effect on the Norwood 
Circulation, and so surgical intervention is unnecessary. When to intervene surgically 
is a very difficult decision to make. Surgeons want to avoid unnecessary surgical 
intervention as neonate patients, at this point, just went through the Norwood 
Procedure and are usually very fragile. On the other hand, surgeons fear the risks that 
are caused by not correcting NAO surgically. Coarctation severity index (CoI) has 
been the rule of thumb when it comes to the decision of intervening a NAO surgically 
or not.  
However, in a recent unpublished clinical study, clinicians in Great Ormond 
Street Hospital in London UK found that Norwood patients with different aortic arch 
morphologies tend to respond differently to narrowing coarctation (COA) (Giardini 
A. ). For example, coarctation severity does not seem to directly predict Single 
Ventricular Power (SVP) change. Some patients with very low CoI (severe COA) in a 
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tubular aortic arch show little increase of ventricular power change and pressure 
gradient with additional narrowing. Conversely, ventricular power increase in patients 
with dilated arch tends to be more rapid than in those with tubular arch. This 
observation makes coarctation treatment planning even trickier.  
 This clinical hypothesis has not been validated due to the difficulty of 
monitoring the pressure gradient across NAO precisely with the development of NAO, 
and it is even more difficult to precisely examine the global hemodynamic response 
to NAO clinically. Hence, in vitro modeling may help to validate the hypothesis and 
understand the hemodynamics of these cases. 
Background and methods of in vitro multi-scale patient-specific study  
 
There are three basic realms in which hemodynamics can be studied: in vivo, 
in vitro and in silico. In vivo methods involves taking necessary vital measurements 
on a living human or animal subject, in vitro method means running tests on a fully 
characterized mechanical system with known parameters under a highly controllable 
laboratory environment, and in silico means numerical simulation and modeling on a 
computer. When testing clinical hypotheses, the best choice of obtaining meaningful 
measurements is in vivo study, for it is conducted under the native physiological 
environment (Camp, 2009). However the disadvantages of in vivo study are that it is 
dangerous to perform, expensive and unethical, and limited in number. These 
drawbacks call for the need to build a less expensive, compact, and easy to use in 
vitro system or in silico model, making a large number of experimental runs practical.  
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When designing a model either in vitro or in silico, there is the common 
problem of scale. Fluid mechanics in a test section naturally concerns fine spatial 
resolution, down to the Kolmogorov scale. It is completely impractical to model the 
entire living body at this level of detail, when only pressure and flow boundary 
conditions are required for the test section. However, in any medical study, the main 
question is how the test section, such as an anastomosis site or a shunt, or a device 
such as a check valve, will interact with the body. One solution is to use a system of 
time-varying ordinary differential equations to represent the pressures and flows of 
the several districts of the body as lumped parameters with no spatial resolution, thus 
providing a zero-dimensional or 0D model. Concurrently, a three-dimensional or 3D 
model of the surgical site is developed and the equations of motion, a set of partial 
differential equations, solved. The pressure and flow rate variables in the 0D model 
are then coupled with the inflow and outflow boundary conditions of the 3D model.  
This coupling of a 0D LPN to a 3D fluid test section is termed “multi-scale” or 
“multi-domain” (Migliavacca, 2005). The LPN addresses the systems-level pressures 
and flows throughout the circulation. The evolving fluid dynamics in the test section 
address the fine-scale local-level details of flow in the 3D domain to answer questions 
such as wall shear stress, stagnation zones, or specific pressure gradients. The 
exchange of information between models determines the time-based solutions. The 
resulting flows and pressures at the boundaries feed back into the LPN via the inlet 
and outlet boundaries. This feedback is the hallmark of the multi-scale strategy. A 
well-designed LPN will not only create the expected baseline conditions for the 3D 
section, but will also respond with the correct sensitivity to changes in flow through 
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the 3D section. Thus, a multi-scale hemodynamics model can predict how an 
experimental vasculature or flow device will perform in the dynamic environment of 
a patient’s body. 
The various elemental values, which are the “parameters” of the LPN, can be 
set to generic (or common) values for a patient of a given body area size, to produce 
predictive results, or they can be tuned to match as much specific clinical information 
as is available for a given patient. Setting these parameters is not necessarily easy. 
The values of parameters such as resistance, inertia and compliance of complex 
shaped vessels cannot be measured directly in the clinic, only estimated from 
available pressure and flow data. Likewise, the test section can be designed either 
with a generic three-dimensional shape of the surgical site, or it can be made patient-
specific using MRI, CT, or other imaging data from the patient’s own anatomy. The 
uniqueness of patient-specific physiologies affects surgical outcomes significantly. 
(Hornik, 2011).  
Figure 1.7a shows an example schematic of a multi-scale model for the 
Norwood circulation, in the electrical circuit analogy style. The flow resistance and 
volumetric compliance elements of a LPN are conveniently represented using 
electrical resistance and capacitance symbols. The test section (aortic arch) geometry 
was taken from MRI of a pre-Glenn patient in London (Biglino, 2012). Figure 1.7b 
shows a schematic of the same model in the “plumbed” style within a mock 
circulatory system, using adjustable valves for flow resistance and compressible air 
chambers for compliance. This in vitro patient-specific mock circulatory system 
(MCS) illustrates a multi-scale scheme. It is based on practical representation of the 
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overall circulation as 0D lumped parameter networks (LPN) made up of plumbing 
parts, and patient-specific 3D models of the test section, which is the blood volume at 
the site of the anastomosis, shunt, or other intervention. Three-dimensional test 
sections, called phantoms, of varying shapes can be built by rapid prototyping 
technology from the prepared imaging files and inserted directly into the MCS test 
loop. The LPN can be retuned to match the desired conditions of the simulation. 
 
Figure 1.7. A: schematic of reduced lumped parameter network model used for the 
mock circulatory system and measurement points used throughout the system. 
A: Electrical schematic of the circuit, where Cprox = proximal compliance, Cub = upper 
body compliance, Rub = upper body resistance, Cp = pulmonary compliance, Rp = 
pulmonary resistance, Clb = lower body compliance, and Rlb = lower body 
resistance. B: Plumbing schematic representation of the circuit, showing (1) the PC-
controlled piston, (2) Berlin Heart, (3) Cprox, (4) test section, (5) Clb, (6) Rlb, (7) Cub, 
(8) Rub, (9) Cp, (10) Rp, (11) atrial chamber (Biglino, 2012). 
State of the art stage 1 palliation modeling 
The previous modeling of stage 1 palliation is limited compared to stage 3 and 
stage 2 modeling due to the unique pathology in each case, and difficulties with the 
complex fluid dynamics in the shunt (Corsini, 2012). Biglino et al provides a detailed 
review of the engineering tools to study the first stage palliation of HLHS (Biglino, 
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2013). Also, Pennati et al provided a comprehensive literature review regarding the 
methodology of modeling systemic to pulmonary shunts in newborns with HLHS 
(Pennati, 2010).  
In silico models were developed during the past decades to study the Norwood 
circulation. The first attempts to model Norwood circulation dates back to 1994 when 
Barnea et al described an analytical model to model the whole cardiovascular system. 
Barnea and colleagues developed two mathematical models at 1994 and 1998 to 
investigate the effect of distribution of flow between systemic circulation and 
pulmonary circulation on systemic oxygen delivery in neonates with HLHS. Barnea 
applied simple theoretical analysis, finding that the pulmonary to systemic flow ratio 
Qp/Qs is associated with systemic arterial oxygen availability (Barnea, 1994) (Barnea, 
1998). Later on, 3D CFD models were developed by several groups. Migliavacca et al 
developed a 3D realistic CFD model to study the effect of shunt size on pressure drop 
and flow change across the shunt (Migliavacca, 2000). Song et al described a 3D 
simplified CFD model to study the effect of shunt size change on energy loss (Song, 
2001). Waniewski et al. developed a 3D realistic model of the left subclavian artery 
(LSA), the left pulmonary artery (LPA), and the mBT shunt to study the effect of 
shunt size  (3 and 4 mm) and shunt shape (straight and curved) on the wall shear rates 
(Waniewski, 2005). Malota et al developed a 3D realistic CFD model of the LSA, the 
LPA, and the mBT shunt to study the effect of an axial pump into the mBT shunt, and 
the effect of size on the pressure gradient and flow across the shunt (Małota, 2007).  
These early studies were all limited by the fact that those models, although 
providing very detailed local or global hemodynamics, cannot be used to describe the 
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effect of changing body variables such as SVR on the local or global hemodynamics; 
they lacked the feedback to the remainder of the circulation. The first attempt to break 
this limit is made by Migliavacca and colleagues in 2001, they presented a 0D 
lumped parameter model to simulate the whole cardiovascular system in order to 
investigate how changes of shunt size, PVR, and SVR could change the flow and 
pressures throughout the BT shunt (Migliavacca, 2001). This multi scale modeling 
method overcomes the limitation of previous models by coupling the shunt hydraulic 
behavior to the response of the whole system. Pennati et al published a study using 
the same method of 0D LPN modeling to study the PVR and shunt size’s effect on the 
pressure gradient across the shunt in the same year.  
Laganà et al first coupled the 0D LPN of circulation and the 3D model of a 
shunt in order to compare the coronary and pulmonary flow in a central shunt with an 
mBT configuration with three shunt sizes (Laganà, 2005). They found that average 
shunt flow rate is relatively higher for the central shunt option. And also, as expected, 
shunt flow increase as the shunt size increase. After that, several studies have been 
published using the multi-scale method. Migliavcca et al., using a 0D-3D coupled 
multi-scale method, developed a model of the whole cardiovascular system to study 
the effect of shunt size and different surgical techniques on the right ventricle’s 
Pressure-Volume (PV) loop (Migliavacca, 2005). Bove et al., using a method similar 
to Migliavacca’s, developed a 3D-0D coupled multi-scale model and validated the 
computational results against clinical measurements, in order to investigate the how 
different surgical techniques would change the ventricular performance in addition to 
pulmonary and coronary perfusion (Bove, 2007). Hsia et al. developed a 3D-0D 
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coupled model of Norwood circulation with a 5-mm RV-PA shunt, a RV-PA shunt 
with 3- or 2-mm stenosis at the RV anastomosis, a stenotic RV-PA shunt plus a 3.0- 
or 3.5-mm mBT shunt, or a 3.5-mm mBT shunt, in order to discuss the different cases’ 
effects on hemodynamics. It was found that proximal stenosis of the RV-PA shunt 
results in decreased pulmonary blood flow, total CO, and oxygen delivery. Addition 
of a 3.0- or 3.5-mm mBT shunt causes pulmonary overcirculation, lowers systemic 
oxygen delivery, and decreases coronary perfusion pressure. Diastolic runoff through 
the stenotic RV-PA shunt increases retrograde flow back into the single ventricle 
(Hsia, 2009). Corsini et al. used a 3D-0D coupled multi-scale model of the whole 
cardiovascular system to simulate the hybrid stage 1 circulation with stented ductus 
arteriosus and banded pulmonary arteries. The effects of changing degrees of 
pulmonary banding and different stent sizes on Qp/Qs flow ratio, CO, and oxygen 
delivery were assessed. It was found in this study that balanced systemic and 
pulmonary blood flow is strongly associated with the degree of pulmonary arterial 
banding but not with the size of the ductal stent (Corsini, 2011). 
Physical experimental models have also been developed for the purpose of 
validating clinical hypothesis and CFD models. Models usually take the form of MCS 
and can be of different complexity according to different purposes of the test.  
The first attempt of in vitro modeling stage 1 palliation dates back to 1998, a 
pulsatile flow model was developed by Tacy et al to evaluate pressure gradient across 
the modified Blalock-Taussig shunt. This paralleled systemic and pulmonary 
circulation flow model included a pulsatile flow generator, Gore-Text BT shunt, and 
multiple flow resistor and compactor.  The purpose of this study was to compare the 
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actual pressure gradient measured in vitro against those predicted using Echo Doppler 
probe for various shunt sizes. This study showed that good agreement between 
Doppler predicted pressure gradient and measured pressure gradient only occurs 
when shunt diameter is >5mm. Otherwise, Doppler predicted pressure gradient 
underestimates the in vitro measured actual pressure gradient (Tacy, 1998). A later 
study conducted by DeGroff et al focused on the same topic using a similar method. 
DeGroff et al developed a pulsatile flow model similar to Tacy et al, and a numerical 
model to study the accuracy of Doppler predicted pressure gradient under different 
scenarios: inlet stenosis shunt, diffusive stenosis shunt, outlet stenosis shunt, and no 
stenosis shunt. This study used both numerical method and in vitro method to confirm 
that Doppler predicted pressure gradients underestimates actual pressure gradients at 
high pressure gradient region for all shunt configurations (DeGroff, 2000).  
Pennati et al developed an in vitro flow model to study the flow and pressure 
relationships in mBT shunts. This model used Gore-Tex shunts and compliant tubes 
to account for the distensibility of vessels, and also realistic surgical anastomoses 
were realized in the flow model. This study showed that pulmonary artery pressure 
change could affect the pressure flow relationship; this effect is significant at distal 
site. However the total pressure drop is not affected by the changes of pulmonary 
pressure. Effect of surgical anastomoses sites was investigated in this study; surgical 
anastomoses could cause cross section reduction at the site of suture, and should be 
taken into account in the future (Pennati, 2001). Bakir et al looked into vascular 
resistance-flow relationship using an in vitro model. This flow model used a 
ventricular assist device (VAD) to generate pulsatile flow, and was tested over a 
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range of pulmonary vascular resistance (Bakir, 2006). Biglino et al developed a MCS 
with a patient-specific approach to investigating HLHS physiology. Patient specific 
neoaortic morphology was obtained using cardiovascular magnetic resonance (CMR), 
and was made using modern 3D printing technology. The pulsatile flow was powered 
by a VAD driven by a computer-controlled hydraulic pump, and multiple resistive 
and compliant flow elements were employed around a 3D printed patient-specific 
neoaortic anatomic model to model the circulation of Norwood patients (Biglino, 
2012). The model was initially developed to study the circulation of a Norwood 
patient, in which the mBT shunt was a non-valved conduit branching off from the 
innominate artery. Later the model was modified so it can also be used to study the 
circulation of a Norwood patient with a Sano shunt by directing a portion of fluid 
from the VAD to the pulmonary branch (Biglino, 2013). Such a MCS uses a multi-
scale method that combines the 3D neoaortic model and 0D vascular LPN model, so 
it can be used to study the local fluid mechanics and as well as global hemodynamics 
of Norwood patients.  
State of the art aortic coarctation modeling 
Though modeling of the COA is more recent compared to the modeling of 
Norwood circulation, many in vitro and in silico COA studies have been published 
during the last decade. LaDisa et al published a literature review of recent methods of 
evaluating COA both computationally and experimentally (Ladisa, 2010).  Like 
modeling of stage 1 palliation, various methods have been applied to model COA 
ranging from 0D LPN, idealized in vitro models, 3D simplified and realistic CFD 
models, multi-scale 0D 3D coupled models, and currently reaching the patient-
specific modeling level.  
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In an early attempt to model aortic COA, De Mey et al. set up an idealized in 
vitro model to validate the clinical hypothesis that, even after successful repair of 
coarctation, Doppler derived pressure differences is still high without significant arm-
leg pressure differences. De Mey combined in vivo patient and control data, and an in 
vitro hydraulic model, finding that the reliability of Echo Doppler is doubtful when 
evaluating the post-operation coarctation patients (De Mey, 2001). Subsequently, a 
simplified 3D CFD model of aorta and pulmonary arteries was generated by Pekkan 
et al. to study the embryonic aortic arch at late gestation. An in vitro validation 
accompanied this computational study to validate the computational results that large-
scale recirculating flow exists in the aortic arch proximal to the ductus arteriosus (DA) 
(Pekkan, 2008).  
As pointed out by De Mey et al. at 2001 and several previous clinical studies 
(Seifert, 1999) (Barth, 1987) (Marx, 1986) (Sharma, 1992), the accuracy of Echo 
Doppler prediction has always been an interest of the researchers. Baumgartner et al 
developed an in vitro study concerning the effect of stenosis geometry on the 
Doppler-catheter gradient relation. Stenoses of various geometries were 
simultaneously studied with Doppler and catheter pullback. Doppler predicted 
pressure gradient was compared with catheter measured pressure gradient for each 
case. They found, in the case of the highest gradients across flow obstructions that 
occur in the vena contracta, that Doppler predicted gradients have good agreement 
with catheter measurements. However, these gradients are significantly greater 
than catheter gradients that are measured farther downstream, due to pressure 
recovery. In an important finding, the overestimation phenomenon is most likely to be 
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considered clinically significant with a stenosis shaped like a gradually tapering inlet 
and outlet with an outflow angle greater or equal to 20 degrees (Baumgartner, 1993).  
Giardini et al described a steady flow model with simplified COA model of 
different length and diameter in order to compare the Doppler predicted pressure 
gradients and in vitro catheter measured results (Giardini, 2010). This study found out 
that Doppler overestimates actual pressure gradient at the high pressure gradient 
region. Figliola et al used a similar method to assess the accuracy of Doppler 
predicted pressure gradient in stage 1 circulation with varying COA (Figliola, 2010). 
Keshavarz-Motamed et al. developed an in vitro multi-scale modeling 0D 3D coupled 
model and a 0D LPN to evaluate the severity of aortic coarctation, suggesting two 
new parameters: COA Doppler velocity index and COA effective orifice area, instead 
of the current prevalent criteria, coarctation index. The model provided was validated 
by in vitro measurements and clinical measurements (Keshavarz-Motamed, 2012) 
(Keshavarz-Motamed, 2011). Concerning the COA’s impact on the left ventricle 
work load, Keshavarz-Motamed et al also used their model to assess the PV loop of 
the left ventricle, investigating the extra ventricular work due to COA.  
During recent years, the development of MRI and MRA made patient-specific 
studies of COA possible. Multiple studies used MRI or MRA technology to obtain 
patient-specific anatomy of the aorta, and then conduct in vitro or in silico studies. 
Kim et al. developed a multi-scale in silico model with 0D LPN coupling with 3D 
patient-specific model. This CFD model concerns several scenarios including a 
normal human thoracic aorta under rest and exercise conditions, and an aortic 
coarctation model under pre- and post-interventions. The results of this study 
26 
 
demonstrated pressure and flow at various sites of the aorta and also evaluated 
ventricle function by constructing a PV loop from the LPN. Velocity fields within the 
domain of aorta, and mean wall shear stress of the aortic wall are also assessed in this 
study (Kim, 2009). LaDisa et al. expanded the model developed by Kim et al. and 
conducted two in silico studies. One study looks into the alteration of wall shear 
stress in aortic coarctation patients after being treated by resection with end-to-end 
anastomosis. The models are 3D patient-specific CFD models, with anatomy of the 
aorta extracted from imaging and blood pressure data for both COA patients and 
control groups. CFD analysis incorporated SVR and SVC in order to generate 
realistic blood flow velocity, time-averaged wall shear stress (TAWSS), and 
oscillatory shear index (OSI) results. Comparing the results of patients group and 
control group revealed several statistically significant local differences regarding 
TAWSS and OSI. Also, unique locations for plaque formation were identified 
(LaDisa, 2011). Another computational study published by LaDisa et al. used four 
patient-specific 3D CFD models. This study concerns the understanding of COA 
hemodynamic indices under resting and non-resting conditions, such as cyclic strain, 
TAWSS and OSI. They found that systolic BP increased and mean and peak ΔBP 
increased for the moderate native COA patient, and cyclic strain increased proximal 
to the coarctation for native CoA patients, but reduced throughout the aorta after 
treatment (LaDisa, 2011).  
Biglino et al developed an in vitro 0D-3D coupled pulsatile MCS to model the 
stage 1 palliation circulation with an mBT shunt and aortic coarctation of three 
different severities (Biglino, 2012). Peak pressures right before COA, right after COA, 
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and distal to OCA were observed for three cases, demonstrating different degrees of 
pressure recovery. Change of global flow distribution caused by different severity of 
COA was also investigated in this study. Subsequently, Biglino et al. used similar 
methods and constructed a MCS for the stage 1 circulation with a Sano shunt (Biglino, 
2013). Two test sections were employed in this study, a normal aortic arch and an 
aorta with coarctation. Effect of COA was successfully demonstrated. Next they used 
the in vitro patient-specific MCS described before to validate an in silico model, and 
to help make design decisions such as choosing appropriate CFD mesh and flow 
regime, and highlighting the importance of in vitro data (Biglino, 2014). Itu et al. 
published a study illustrating the process of in silico multi-scale modeling of aortic 
coarctation using a 0D-3D coupled model starting from extracting patient specific 
aorta anatomy from MRI. They constructed the model, applied the boundary and 
initial conditions, and eventually compared the in silico results with the in vivo results, 
which showed satisfactory correlation (Itu, 2013). Corsini et al. recently developed a 
multi-scale model investigating the effect of mBT shunt size and CoI on coronary 
perfusion after Norwood Operation. They found that simultaneous presence of a large 
shunt and severe coarctation can have adverse effect on coronary perfusion, and 
hypothesize that this could be the reason for poor clinical outcomes. 
Limitations and future advances  
Though the past decades saw a great development in modeling of the 
Norwood circulation and COA as stated in Sections 1.5 and 1.6, there are still 
limitations associated with current modeling studies (Pennati, 2010, Biglino, 2013).  
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1. Despite the emergence of the patient-specific model, most of the models now 
being used to study Norwood Circulation continue to be generic models. This is 
due to caution in performing the necessary interventional measurements, as well 
as the high cost of associated measurements. Unless a patient presents a need for 
intervention and the necessary measurements, they are not taken. 
2. Patient specific values such as PVR and SVR are rarely realized in the models. 
3. Previous global scale models are not capable of demonstrating the patient-specific 
arterial morphological effects, such as the effect of aortic arch morphology.  
4. Previous 3D local scale studies are conducted predominantly by prescribing or 
enforcing boundary conditions. In those methods, there is no interaction of the test 
section/domain with the rest of the circulation.  
5. Few COA studies focus on the effect of COA on the global or systems-level 




Research Objectives and Study Purpose 
 
The research motivations are: 
 Simulate the surgery using in vitro methods, develop therapies, and evaluate 
effectiveness. 
 Improve understanding of the indications requiring intervention for neoaortic 
coarctation.  
 Provide clinicians supporting information in choosing among surgical options.  
In support of these motivations, the study specific aims are. 
1. Replicate the Norwood circulation using an in vitro multi-scale model. 
The aim is to generate cardinal physiological pressure and flow signals of 
Norwood circulation. A multi-scale in vitro patient specific model is built coupling an 
LPN network of the Norwood circulation around a 3D patient-specific aortic model. 
The system is tuned to patient specific R C values, and clinical values.  Physiological 
flow rate and pressures measurements are made in the upper body, lower body, 
pulmonary system and aorta.  
2. Validate the system’s function using five patient cases having different 
morphologies. 
The aim is to validate the multi-scale model using clinical measurements of 
flow rate and pressure. Five patients with different physiologies and morphologies are 
used. Statistical methods are applied to compare agreement between experimental and 
clinical measurements.  
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3. Study the system-level effects of coarctation on the hemodynamics of each 
patient with mBT shunt and differing aortic morphology. 
The aim is to study the system-level hemodynamics responses to NAO 
narrowing. The severity of coarctation is progressively increased within the 
descending aorta for each patient. System-level changes are measured and ventricular 
power calculated for each case.  
4. Compare systems-level response of mBT patients with the alternative RVS 
(Sano) procedure, including effects of coarctation severity.  
The aim is to compare the system-level hemodynamic responses and 
ventricular power changes occurring between the mBT and RVS procedures among 





IN VITRO MULTI-SCALE PATIENT-SPECIFIC STAGE 1 MOCK SYSTEM 
 
Three studies were conducted in order to achieve the aforementioned 
objectives and aims. This chapter discusses the research methods that were utilized in 
these three studies. 
Selection of Patients and Anatomical Models 
Five patients were identified and selected from clinical information collected 
from four medical centers under appropriate Institutional Review Board approvals 
(University of Michigan (UM), Great Ormond Street Hospital (GOSH), and Medical 
University of South Carolina (MUSC)). Four out of five patients had been diagnosed 
with HLHS and underwent a Norwood Procedure with mBT shunt. One patient had 
been diagnosed with Hypoplastic Right Heart Syndrome (HRHS) and underwent a 
Norwood Procedure with mBT shunt. The five patients each presented a different 
aortic morphology ranging from hypoplastic tubular to strongly dilated. Clinical 
measurements of the patients included ascending aortic pressure and pulmonary 
wedge pressure measurements by cardiac catheterization, mBT shunt flow and 
ascending aortic flow velocity measurements via either echo Doppler velocimetry or 
magnetic resonance. Clinical measurements of volumetric flow rate (Q) and blood 
pressure (BP) measurements of each case were used to assess local resistance and 
compliance values. Physiological characterization and clinical measurements are 
given in Table 2.1 in which patients are designated as MUSC7, GOSH22, MUSC2, 
UM5, and UM10. MUSC7 is the one with HRHS. 
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 For each patient, a test section or phantom was created based on 
segmenting magnetic resonance (MR) imaging data. Commercial software (Mimics; 
Materialise NV, Leuven, Belgium) was used to prepare the virtual images for additive 
manufacture as previously described. (Schievano, 2007) The aortic arch, descending 
aorta, major superior arteries and shunt-brachiocephalic artery anastomosis were 
maintained patient-specific accurate. The coronary arteries were not modeled. The 
inlet to the aortic valve root was extended to provide for a connection to a heart pump. 
The phantoms were printed by stereolithography using a transparent rigid resin 
(Watershed XC 11122; DSM Somos, Elgin, IL). This transition is illustrated in Figure 
2.1. 
 
Figure 2.1 Aortic phantoms are constructed from 3D magnetic resonance image (left), 
prepared and manually modified using a commercial software in order to better fit the 
hoses (center), and then printed using 3D rapid manufacture.  
The virtual models and resulting test sections are shown in Figure 2.2. Note 
that in Figure 9, noticeable extensions were built in from ascending aorta roots. The 
extensions are not physiological but were implemented for the purpose of better 




Parameters Patient Values 
 
MUSC7 GOSH22 MUSC2 UM5  UM10 
HR (bpm) 118 115 120 90 140 
BSA (m2) 0.26 0.27 0.3 0.28 0.34 
Shunt Diameter (mm) 4.0 3.5 3.5 3.5 3.5 
MAP (mm Hg) 51 50 56 54 73 
SAP (mm Hg) 7 6 6 5.5 4 
Qp/Qs  0.80 1.16 0.88 0.78 1.52 
Qub/Qlb  1.90 1.39 0.97 2.64 2.67 
Native Coarctation 
severity  None Slight Slight Moderate Severe 












Table 2.1 Physiological characterization and clinical summary of the 5 patients 
selected. 
 
Figure 2.2 Aortic geometry of patients: (a) MUSC7, (b) GOSH22, (c) MUSC2, (d) 
UM5, and (e) UM10. The upper images are the blood volumes from MRI (with 
extensions added), and the lower photos show the actual test sections. 
 
Mock Circulatory System Design 
The mock circulatory system (MCS) of the Norwood circulation is a physical 
realization coupling an LPN of the circulation with an anatomically accurate, three-
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dimensional (3D) test phantom of the neoaorta. A detailed multi-compartment LPN of 
the Norwood circulation was described by Hsia et al and applied here (Hsia, 2011). 
The LPN consists of three major circulation branches: upper body, lower body and 
pulmonary branch. This detailed model was reduced to a more practical level by 
using fewer elements through Thevenin impedance matching (Vukicevic, 2014) 
(Vukicevic, 2013), as depicted in Figure 2.3. Each branch is comprised of one distal 
resistance element and a compliance element (Westerhof, 2005). Inertance is realized 
by the mass of fluid. The system is tuned initially to a particular physiological state 
using generic reference values that are scaled using body surface area (BSA) for each 
impedance element, as previously described (Baretta, 2011), and then appropriate 
elemental values are adjusted based on available patient-specific clinical information. 
The MCS shows modifications from the previous study (Biglino, 2012): each superior 
artery is coupled with its own compliance element, each test phantom and system 
setup uses known clinical patient data. Flow rates and pressures measured throughout 




Figure 2.3 Reduced lumped parameter network model used for mock circulatory 
system with measurements points shown. R, resistance; C, compliance; P, pressure; Q, 
flow rate; C.O., cardio output; asc.ao, ascending aorta; prox, proximal; pul, 
pulmonary; sh, shunt; lb, lower body; atri, atrium; bc, brachiocephalic artery; lcc, left 
common carotid artery; lsc, left subclavian artery; l, left upper body vein; r, right 
upper body vein; d, distal resistance. 
Figure 2.4 shows the physical MCS equivalent to the schematics in Figure 2.3. 
As seen, the lengths of tubing were minimized in order to reduce parasitic inertance, 
that is, the added inertance due to the experimental set-up connections as compared 




Figure 2.4. The bench top stage 1 Norwood palliation MCS shown is a physical 
realization of the model described in Figure 2.3. 
Pulsatile flow pump: Ventricular Assis Device (VAD) 
A ventricular-assist device (VAD) (Excor®, Berlin Heart 25 cc, Berlin, 
Germany) was used to develop the pulsatile aortic pressure and drive the cardiac 
output fulfilling the role of the single ventricle heart. This VAD consists of two sides:  
a blood filled side and an air filled side, separated by a flexible membrane. The VAD 
was driven pneumatically under computer control: high pressure is applied during 
systole and a small vacuum pressure is applied during diastole.  High side compressed 
air is regulated to a desired pressure using a pneumatic needle valve. Vacuum 
pressure is regulated to a desired pressure using a piezo proportional pressure 
regulator (Type: PRE-U2, Hoerbiger, Schongau Germany). A 3 way valve (Model: 
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225B-111CAAA, MAC Valve, Dundee, MI, USA) was controlled by a computer and 
alternates between high air pressure and low air pressure. A computer generated 0-5V 
square wave was used to realize this alternating action in which high-level voltage 
(5V) to the 3-way valve allows high pressure to pass to the VAD, while low level 
voltage (0V) to the valve allowed low vacuum pressure to pass. The duration of high 
pressure to vacuum pressure within one heartbeat cycle determined the systolic ratio 
and the rate of each cycle determined the heart rate. The high pressure level and low 
pressure levels were adjusted to achieve the desired mean ascending aortic pressure 
while ensuring complete filling of the VAD. The VAD and its control system are 
shown in Figure 2.5.  A sample of typical VAD air and liquid side pressure is shown 
in Figure 2.6. 
Additionally, a proportional pressure regulator (Tecno-series, Hoerbiger, 
Germany) was tested to control high-side air pressure and could allow for automatic 
baroreceptor response (mean aortic pressure) or autoregulatory response (cardiac 
output) based on feedback from pressure transducers and flow rate probes. A 
proportional regulator sets its pressure regulation based on a supplied voltage signal, 
such as from the computer controller. This would introduce closed-loop control of the 




Figure 2.5. (a) Top view of the VAD (upper left) showing the air side and the 
isometric view of the VAD. (b) Driving system of the VAD. 
 
Figure 2.6. A sample of typical VAD air and liquid side pressure. 
Resistive Elements 
 Each resistor (R) in the LPN network was realized using either a constant 
diameter tube or an adjustable needle pinch valve (Vukicevic, 2014). Figure 2.7 























in the system as resistive elements. Resistance value settings were confirmed under 
steady flow conditions based on pressure drop and flow rate. Resistance value control 
was confirmed using a steady flow condition based on 𝑅 =
∆𝑃𝑛
𝑄
, where n is 1 for 
laminar flows and n approaches ½ for turbulent flow through valves and stenosis. 
Given the low flow rates, nonlinearity was not a problem. The values for Rshunt, PVR 
UBSVR and LBSVR were calculated based on mean pressure and flow rate 
















  (2.4) 
Resistances values used for each patient model are given in Table 2.2. The 
experimental resistance values are compared with their clinical references in Table 








Air chambers were used as the compliance elements, where the compliance 
was provided by the compressibility of a predetermined volume of trapped air within 
a closed rigid cylinder (Vukicevic, 2014) (Vukicevic, 2013). The compliance value is 
calculated as 𝐶 =
𝑉
𝑃 𝑎𝑏𝑠
, in which V denotes the amount of air in the chamber, Pabs 
denotes the absolute pressure (working pressure) within the chamber. Such a rigid 
cylinder was made from a cylindrical acrylic tube, typically 50 to 75 mm in diameter, 
with one end closed off using a pipe cap and the other closed using a plumber’s test 
plug (Oatey Corp, Cleveland, OH). The test plug could be moved to a position within 
the cylinder to achieve the desired air volume. Figure 2.8 illustrates an air chamber 
used in the system. Compliance values used for the tests are given in Table 2.2 for 
each patient model. 
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In order to compensate for the rigidity of the aortic phantom, a proximal aortic 
compliance air chamber was installed between the VAD and the phantom (Biglino, 
2012). This technique enabled capturing the compliance of the aorta so as to enable a 
realistic ascending aortic pressure wave with realistic pulse pressure (i.e., the systolic 
to diastolic pressure).  
 
 
Figure 2.8: An air chamber in the system. 
Atrial tank 
Atrial pressure was set using a constant head tank. The atrial pressure was 
adjustable but maintained constant for each test case. The atrial head tank was made 
of a 100 mm diameter acrylic tank with a standpipe. 
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System Tuning and Setup 
Preparation of the test bed for operation consists of tuning the LPN and setting 
the mean aortic and atrial pressures. The resistance elements of the LPN were 
adjusted to desired values under steady flow conditions by measuring pressure drop 
and flow rate across each corresponding branch of the system. The compliance 
elements were adjusted to the desired value by setting the correct liquid head pressure 
and air volume within each element. The atrium head tank was adjusted to attain the 
desired mean atrial pressure.  The VAD air-side pressures were then adjusted to 
achieve the desired liquid-side mean aortic pressure. Lastly, the aortic compliance 
element was adjusted to achieve a desired pulse pressure. 
Blood Analog Test Solution 
Preliminary tests were conducted using a saline solution (30 cc per 4 L water) during 
setup and staging. A saline-glycerin blood analog was used (1060 kg/m3, 3.3 x 10-6 
m2/s at 22oC) during final tests.  
Global Measurements 
Measurement points for pressure and flow rate are indicated in Figure 2.3. 
Flow rates were measured with electromagnetic probes (P600 electromagnetic flow 
probes (P600 series, Carolina Medical Electronics, King, NC), each connected with 
its own flow meter control unit (Model FM501, Carolina Medical Electronics, King, 
NC). Calibration and zeroing of the flow measuring apparatus was conducted in zero 
flow condition per manufacturer’s instructions. Ground wires were placed within the 
atrium head tank in order to stabilize the signals and reduce electrical noise. 
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Pressures were measured using either catheters or at wall taps connected to 
liquid-filled transducers (DTXplus, BD Medical Systems, Sandy, UT). Each pressure 
transducer was connected to a bridge amplifier (Model 2100, Measurements Group 
Inc., Raleigh, NC), which allowed for null adjustment and voltage amplification. The 
transducers have a stated sensitivity of 50 µV/mmHg. Calibration of each transducer 
and bridge system was confirmed by applying a known hydrostatic pressure to the 
sensor (literally, a known head of water provided by an elevated water-filled beaker) 
and using a two point pressure head calibration procedure.  
All the date was acquired using a DAQ data acquisition system, which was 
comprised of a DAQ board and LabVIEW software (USB 6211, LabVIEW 8.6; 
National Instruments, Austin, TX), and measurements sampled at 160 Hz. A 0-5V 
square wave was generated from DAQ system to control the VAD 3-way valve, with 
the frequency and duty cycle of such square wave adjusted within LabVIEW. Figure 





Figure 2.9: The architecture of the pressure measuring system, flow rate measuring 
system and data acquisition system. 
 For each patient case, compliance and resistance values were set under 
steady flow conditions and then mean aortic and atrial pressures, heart rate and 
systolic ratio were fixed to the clinical values (Table 2.2). The aortic proximal 
compliance was adjusted to minimize overshoot in the systolic pressure signal from 
the VAD. System-level measurements were recorded for each test case and statistical 
values determined over 25 contiguous cardiac cycles, a number deemed sufficient to 
achieve stationary mean values. Numerical trapezoidal integration was performed on 















Regression analysis was performed to quantify the agreement of clinical and 
experimental signals.  For each time-based signal comparison, a scatter plot was made 
of the experimental data magnitudes versus the clinical data magnitudes at 
corresponding time points. Regression analysis (y = x) was then used to quantify the 
agreement and an R2 value computed.  
A paired t test was used to test for any statistically significant difference 
between the clinical and experimental mean values. For all experimental datasets, the 
time-based data over 25 contiguous heart cycles were used. A p < 0.05 was 
considered to indicate a statistically significant difference between the mean values 
calculated from the experimental and clinical datasets. A p > 0.05 indicated that there 
was no significant difference between the two mean values within the variation of the 
two datasets.  
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 MUSC7 GOSH22 MUSC2 UM5 UM10 
Experimental  Clinical  Experimental  Clinical  Experimental  Clinical  Experimental  Clinical  Experimental  Clinical  
Pulmonary  
 
Rpuld (WU) 8.9±0.4 9.46 5.3±0.3 6.00 13.1±0.5 10.17 9.5±0.4 9.15 8.3±0.3 9.50 
Cpul (ml/mmHg) 0.14±0.01 NA 0.22±0.01 NA 0.21±0.01 NA 0.23±0.01 NA 0.2±0.01 NA 
Rsh (WU) 51.9±0.8 51.35 38.7±0.5 39.00 70.7±1.3 77.97 60.3±1.0 57.75 61.0±0.7 58.50 
Upper 
Body 
Rld (WU) 143.2±1.3 
75.00 






Rrd (WU) 143.2±1.3 181.6±2.0 304.9±4.7 152.8±1.3 301.3±3.3 
Clcc (ml/mmHg) 0.90±0.01 NA 0.11±0.01 NA 0.11±0.01 NA 0.13±0.01 NA 0.12±0.01 NA 
Clsc (ml/mmHg) 0.90±0.01 NA 0.11±0.01 NA 0.11±0.01 NA 0.13±0.01 NA 0.12±0.01 NA 
Cbc (ml/mmHg) 0.18±0.01 NA 0.22±0.01 NA 0.22±0.01 NA 0.26±0.01 NA 0.25±0.01 NA 
Lower 
Body 
Rlbd(WU) 138.8±8.8 140.63 123.6±7.0 125.00 157.2±9.4 152.94 181.1±13.6 190.00 364.7±37.3 377.78 













Table 2.2: Elemental values used in the lumped parameter network and corresponding clinical reference. R, resistance; C, 
compliance; prox, proximal; pul, pulmonary; sh, shunt; lb, lower body; atri, atrium; bc, brachiocephalic artery; lcc, left 
common carotid artery; lsc, left subclavian artery; l, left upper body vein; r, right upper body vein; d, distal resistance. Set 




IN VITRO MULTI-SCALE PATIENT-SPECIFIC STAGE 1 PALLIATION 
MODEL VALIDATION RESULTS 
Recall the ultimate goal of this study is to introduce an engineering tool which 
surgeons can use for understanding the general hemodynamics of HLHS patients, as 
well as patient-specific cases, also for clinical hypothesis and surgical technique 
testing, and validate the system against clinical measurements. 
Results 
 For each patient case, the stroke volume, heart rate and systolic ratio and 
the atrial pressure were set to clinical values and the VAD pneumatic pressure 
adjusted to match the ascending aorta mean pressure. The pulse pressure was adjusted 
through the proximal aortic compliance element. At these settings, the pressures and 
volume flow rates were measured throughout the system and compared against the 
clinical pressure and flow rate tracings. The experimentally measured ensemble mean 
values with their standard error are reported in Table 3.1. It should be noted that 
clinical values reported in Table 3.1, due to its in vivo nature and limitation of 
instrumental resolution, have certain uncertainty. The uncertainty of the clinical mean 
pressure measurement is assigned as 1 mmHg, for clinical mean flow measurements, 
the uncertainty is 0.02 lpm; that is, a 1 mmHg difference in pressure and 0.02 lpm 
difference in flow are considered to be clinically insignificant. 
The time-based experimental and clinical ascending aortic pressures are 
shown in Figure 3.1 for three cardiac cycles of four of the five cases; the GOSH22 
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clinical pressure signal was not available. Overall, the experimentally measured 
ascending pressures were able to reproduce the clinical signals well. Subtle 
differences are noted at peak systole. The MUSC2 and MUSC7 clinical signals both 
show a distinct dichrotic notch, which was difficult to reproduce from the 
polyurethane valves used in the VAD.  Systolic contractility was also evaluated by 
comparing the rate of pressure change in systole between aortic pressure signals. 
Differences in dp/dt for MUSC7 and UM5 are less than 6.5% between clinical and 
experimental values, while for UM10 and MUSC2 the differences are about 12% and 
32%. However, the values of the coefficient of determination (R2) range from 0.77 to 
0.9, successfully demonstrating the ability to reproduce the clinical signals in the 
system. Mean pulse pressures compare to within 9% except for MUSC2 at 16%. 
Mean experimental and clinical aortic pressures (Table 3.1) could be set to within 2 
mmHg or within 3%. Differences between the measured and clinical mean aortic 




Figure 3.1. Clinical and experimental pressure signals for each of five patients. 
Pressure tracings includes pulmonary pressure (Ppul) and ascending aorta pressure 
(Pasc.ao). 
With the system set up, the remaining experimental measurements 
demonstrate the consequence of the system tuning. The measured mean experimental 
values of cardiac output were within 0.02 lpm of the clinical measurements for each 
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of the five patients (Table 3.1). Differences between the measured and clinical cardiac 
outputs are not statistically significant (p > 0.37). The corresponding time-based 
ascending aortic flow rates, shown in Figure 3.2(a), follow the physiological 
characteristics of the clinical measurements well as R2 values range from 0.88 to 0.95. 
Time-based pulmonary shunt flow rates are compared in Figure 3.2(b). The 
pulmonary shunt signals match up well with R2 values between 0.72 to 0.85 Shunt 
flow mean values agree to within 0.03 lpm or within 3%. At the systems level, the 
ratio of the pulmonary to system flow rates agree to within 11%.  Differences 
between the measured and clinical pulmonary flow rates are not statistically 
significant (p > 0.13).  
51 
 
Figure 3.2: Clinical and experimental shunt flow rate and cardiac output for each of 
five cases. 
Table 3.1 also shows mean upper body and lower body flow rates. The 
resulting difference between measured mean experimental values and clinical values 
of both upper body and lower body flow rates were within 0.02 lpm. Both upper body 
and lower body flow rates are in close agreement with clinical values, with no 









  MUSC7 GOSH22 MUSC2 UM5 UM10 
CO (l/min) 1.67±0.02 1.86±0.02 1.25±0.02 1.60±0.01 1.65±0.02 
Qpul (l/min) 0.74±0.01 1.01±0.01 0.60±0.02 0.70±0.01 1.00±0.01 
Qub (l/min) 0.62±0.01 0.49±0.01 0.33±0.01 0.65±0.01 0.46±0.01 
Qlb (l/min) 0.32±0.01 0.36±0.01 0.32±0.01 0.26±0.01 0.19±0.01 
PAsc. Ao (mmHg) 51.4±0.29 50.5±0.22 56.3±0.33 54.4±0.33 73.3±0.41 
Ppul (mmHg) 13.5±0.05 11.4±0.05 13.9±0.07 12.2±0.03 12.3±0.06 
dp/dt (mmHg/s)  642.5±0.16 1113.4±0.25 455.5±0.16 398.6±0.24 541.9±0.21 
Pulse pressure (mmHg) 53.4±0.10 74.4±0.21 54.6±0.14 50.3±0.28 63.7±0.14 
Qp/Qs  0.79±0.02 1.19±0.02   0.93±0.03 0.77±0.02  1.54±0.04 
Qub/Qlb  1.940.04 1.360.03 1.030.03 2.500.05 2.420.06 
Clinical 
Values 
CO (l/min) 1.66 1.85 1.26 1.62 1.66 
Qpul (l/min) 0.74 1.00 0.59 0.71 1.00 
Qub (l/min) 0.61 0.50 0.33 0.66 0.48 
Qlb (l/min) 0.32 0.36 0.34 0.25 0.18 
PAsc. Ao (mmHg) 51 50 56 54 73 
Ppul (mmHg) 14 12 12 12 13.5 
dp/dt (mmHg/s)  630 NA 820 424 618 
Pulse pressure (mmHg) 50.5 NA 56.3 59.5 70.2 
Qp/Qs 0.80 1.16 0.88 0.78 1.52 
Qub/Qlb  1.90 1.39 0.97 2.64 2.67 
Table 3.1: Experimental and clinical mean pressures and flow rates (ensemble mean ± standard error). 
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 Overall, looking at the pulmonary to systemic ratio (Qp/Qs), as shown in 
Table 3.1, the experimental results are in close agreement with clinical values and fall 
within their respective standard errors. 
Another variable demonstrated in Table 3.1 is the mean pulmonary pressure. 
The resulting difference between measured experimental values and clinical values 
are within 1 mmHg with exception of MUSC2 and UM10. The differences in these 
two cases are 1.9 mmHg and 1.2 mm Hg, respectively. Differences between the 
measured and clinical pulmonary flow rates are not statistically significant (p > 0.33). 
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 Figure 3.3:  Frequency spectrum analysis of clinical and experimental measurements. 
Frequency content comparisons between the experimental and clinical 
measurements were done using Fourier analysis. The discrete Fourier Transform 
(DFT) of the time series signals were computed using a Fast Fourier Transform (FFT) 
algorithm. The resulting frequency spectra are shown in Figure 3.3. Overall, the 
comparisons reveal that the experimental and clinical spectra are very similar, 
particularly for f < 10 Hz, with mean error < 5%.  Above f >10 Hz the two datasets 
show differences indicating that the experimental system does not have the bandwidth 
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to recreate the higher frequency phenomena found in the clinical signals. These 
higher frequency details could be physiological in nature. For example, the dicrotic 
notch tends to show up near 20 Hz in clinical signals (Oppenheim, 1995) and the 
dicrotic notch is not well modeled with the VAD used in these tests. Some higher 
frequency content could be signal noise from the clinical measurement environment. 
Good agreements were seen at f=0 Hz (1.4% error on average) corroborating the 
results of the paired t-tests that the mean values were well matched. The signals were 
well matched near f= heart rate or about 2 Hz (3.7% error on average), indicating that 
the heart rate and pulsatility of signals were well recapitulated.  
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Figure 3.4:  Impedance spectrum for four cases (GOSH22 lacks clinical 
measurements). 
Impedance calculations were conducted from the pressure and flow spectra. Total 
vascular impedance (TVZ) is used to characterize afterload of the single ventricle. TVZ is 
analogous to electrical impedance and a function of system resistance and capacitance. 





Seven harmonics were calculated in this plot. The impedance at the zero harmonic 
Z (f=0 Hz) is equal to the total vascular resistance (TVR). Good agreements can be 
observed between experimental and clinical measured zero harmonic Z (1.4% error on 
average). This confirms that the total resistance as set within the system is very close to 
the patient’s TVR, as intended. The impedance at the first harmonic Z1 is a function of 
the total vascular compliance (TVC). Overall, it can be seen that differences in 
impedance of compliances are more significant (17% error). This is due to the fact that 
compliance values in the system are based on parameter estimations, rather than clinical 
measurements. The estimation process introduces errors. Overall, the impedance spectra 
results further confirmed that the system setup recapitulated the intended patient –specific 
Norwood circulation faithfully.   
 Discussion 
In this chapter, an MCS that is based on a lumped parameter network model 
coupled with an anatomically accurate, patient-specific aorta test section (3D models) 
was presented. The model was tested using 5 different patient-specific anatomies and 
tuned to their different physiologies.  This multi-scale method allows for circuit 
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tuning to achieve patient specific settings while at the same time, allowing for 
detailed measurements within realistic test sections using accurate time-dependent 
boundary conditions. Based on the excellent validation of experimental measurements 
with clinical measurements, this multiscale in vitro model allows for realistic, time-
dependent boundary conditions at the inflow and outflow boundaries of a three-
dimensional (3D) model of a portion of the circulation, and more importantly, the 
boundary conditions are constantly and appropriately allowed to react by using a 
lumped parameter (0D) network.  
This section has focused on the validation of the MCS as a test bench for 
patient-specific modeling. The VAD input condition fixed the known mean aortic and 
atrial pressures. The hemodynamic systems-level response, determined in terms of 
upper and lower body pressures and flow rates, and the aortic and shunt flow rates in 
five patients, were replicated with reasonable fidelity both in terms of mean values 
and time-based behavior. The advantages of this system are its compact nature, its 
ease of tuning, and its inclusion of relevant circulation branches to achieve realistic 
systems-level information. The test phantoms can be produced quickly, from imaging 
to realization within days. Patient-specific tuning does require more clinical pressure 
and flow rate information than may be typically available with a given patient, 
particularly in neonates. In such cases some elements of the LPN model may need to 
be extracted from available clinical data representative of these patients. 
The in vitro model was operated in an open-loop mode whereby the mean 
aortic pressure and mean atrial pressures were manually fixed and held constant to 
known patient values. Alternatively, the system as configured could be used to 
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maintain a constant cardiac output. The auto-regulation of the heart (i.e. baroreceptor, 
HR variability) happens in the matter of seconds to minutes. It is not the objective to 
study the transient hemodynamics and physiology. In this sense, an open loop model 
should be considered sufficient. Such a model allows for studying the effects of 
parametric variation of one or more changes within the circulation. For example, this 
model can be used to study the effects of aortic coarctation on a patient. Such a 
system will be valuable for recreating the clinical setting so as to evaluate clinical 
situations that cannot usually be measured or attempted in patients, such as novel 
surgical procedures, or simulating interventional measurements, such as 
catheterization.  
When coupled with a rigid anatomically accurate phantom, a proximal aortic 
compliance was needed between the VAD and aortic phantom to achieve a 
physiologically realistic ascending aortic pressure waveform and to prevent large 
amplitude aortic pressure ringing. Vukicevic et al. developed a thin walled, compliant 
phantom of a total cavopulmonary connection, and found that measured system 
pressures and flow rates were not significantly different from those measured using a 
rigid phantom paired with a proximal compliance. Representative values were used 
for the vascular compliance elements in this study. While aortic compliance could be 
extracted from appropriate MRI information, this was not attempted here.  
The system was modified based on a previously described system (Biglino, 
2011). In Biglino et al.’s study, tuning of the circuit was confirmed by qualitatively 
observation of Q and P, quantitative analysis was not made possible due to the lack of 
full set of data from the patients. Additionally, Biglino’s group was not able to 
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produce physiological patient-specific waveform utilizing their system. One 
important observation Biglino et al. made in their study is that VAD’s inflow and 
outflow valve were opened concurrently, causing concurrent presence of flow at both 
end. This phenomenon can be the reason why their waveforms measured were not 
physiologically accurate.  Figure 3.5 shows simultaneous measurements of flow rate 
at inlet and outlet of the VAD in Biglino et al.’s study and this study. In this study, 
inertance of the system and VAD function were carefully manipulated, and the 
concurrent presence of inflow and outflow was eliminated. This is seen in Figure 3.3 
whereby the inflow and outflow signals from the current setup are clearly delineated 
and do not overlap, indicating complete tricuspid and aortic valve closures during 
systole and diastole, respectively. 
As mentioned in section 1.5, there are some other in vitro studies concerning 
the modeling the Stage 1 Norwood Circulation. Few previous models (Biglino, 2011, 
Bakir, 2006) demonstrate validation against any clinical measurements and no 
previous model validates against a wide range of patient-specific morphologies and 
physiologies, as was done here.   
Figure 3.5:  Simultaneous measurement of inflow and outflow of VAD (Berlin Heart) 
(a) Biglino et al. measurement. (b) A sample measurement in this study. 
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Secondly, most of the models (Pennati, 2001; DeGroff, 2000; Tacy, 1998) 
described in previous studies are limited and cannot be used to study the effect of 
changing parameters on both the local and global hemodynamics. For example, 
Pennati et al. described a model in 2001 that contains only the mBT shunt and 
pulmonary shunt as 3D flow domain (Pennati, 2001). The input condition to the 3D 
mBT shunt and PA, rather than being provided by the brachiocephalic trunk, is 
prescribed by a roller pump. This model can be informative only when one concerns 
the pulmonary circulation. However, this model is not capable of reproducing the 
effect of changing SVR on the pulmonary circulation. On the contrary, the model 
described in this dissertation is a 0D-3D coupled multiscale MCS, which contains 
pulmonary, lower body and upper body circulations. With the current model, changes 
in SVR would result in changes of Q and P in brachiocephalic trunk, and hence 
physiological input conditions can be achieved to the downstream mBT and PA 
domain. This feature is very advantageous to understanding this complex and delicate 
Norwood circulation.  
One in silico study published by Corsini et al is the only few studies that share 
some characteristics with this study. Corsini’s group developed a multi-scale 0D-3D 
coupled model to study the effect of coarctation on coronary perfusion after Norwood 
Procedure. They adopted the same method as in this study, they use a patient-specific 
3D aortic flow domain coupled with 0D LPN tuned with patient-specific RCL values. 
They validated their system against clinical measurements and showed satisfactory 
results. Their results are shown in the Table 3.2 below. (Corsini, 2014) 
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    Clinical Data 
Variable Model Mean ± SD Range 
Input       
 BSA (m2) 0.33 0.30 ± 0.04 0.26–0.34 
 SVR (WU m2) 21.4 20.1 ± 9.3 13.3–35 
 PVR (WU m2) 3.63 2.75 ± 0.81 1.35–3.4 
Results       
 CO (mL/s) 30.3 27.4 ± 4.1 21–31 
QDAo (mL/s) 6.7 4.7 ± 1.2 3–6 
QP (mL/s) 16.5 14.1 ± 4.2 9.7–20 
 PAo (mm Hg) 62 56 ± 9 51–72 
 PPA (mm Hg) 15 13 ± 2 11–16 
 EDV (mL) 32 31 ± 3 29–35 
 ESV (mL) 17 14 ± 3 10–18 
      Table 3.2. Comparison Between the Baseline Model (3.5-mm Modified Blalock-
Taussig Shunt<comma> No Aortic Coarctation) and Clinical Values From 5 Patients 
With Same Characteristics Recruited Within the MOCHA Group (Unpublished Data) 
BSA = body surface area; CO = cardiac output; EDV = end-diastolic volume; ESV = 
end-systolic volume; PAo = aortic pressure; PVR = pulmonary vascular 
resistance; QDAo = descending aortic flow; QP = pulmonary flow; SVR = systemic 





IN VITRO MULTI-SCALE PATIENT-SPECIFIC STUDY OF COARCTATION 
IN STAGE 1 NORWOOD PATIENTS WITH MBT SHUNT RESULTS 
In the previous chapter, an in vitro multi-scale patient-specific model was 
developed and validated to model the hemodynamics of a Norwood patient with an 
mBT shunt. Because of the proven reliability of this in vitro multi-scale patient-
specific MCS, it was used to conduct a study of progressive coarctation in Norwood 
patients.  
The goal of this chapter is to further the understanding of the indications 
requiring intervention for neoaortic coarctation (NAO). The study attempts to better 
understand the interaction of NAO severity, ventricular power change, and aortic arch 
morphology. The findings could improve patient management by providing 
supporting information to improve coarctation treatment, such as deciding when 
invasive intervention to treat NAO is necessary and avoid unnecessary procedures. 
Methods 
In order to maintain the native aortic geometry of each patient while simulating 
the geometry associated with increasing coarctation severity, the aortic models for 
each patient were morphed in virtual space to create the narrowing as described 
below. Separate test phantoms for each amount of coarctation severity were printed 
and tested. Tests within the MCS serve to determine the effect of coarctation severity 
on systems-level hemodynamics. In these tests, autoregulation control of cardiac 
 63 
output was simulated by maintaining the cardiac output of each patient constant as 
coarctation severity increased. 
Selection of patients 
Four patients are used in this part of the study: GOSH22, MUSC2, UM5, and 
UM10. Patients’ parameters are given in section 2.1.  
Creation of coarctation 
Severity of coarctation is defined by the diameter at the narrowest site of 
coarctation divided by the diameter of the descending aorta at the diaphragm, and the 
resultant ratio is termed the CoI. The native CoI of GOSH22, UM5 and MUSC2 are 
very close to 1, which indicates mild to no NAO in these four cases, so a progressive 
NAO can be added from CoI=1.0 to CoI=0.3. In UM10 the native CoI was 0.7. 
The subtle challenge of increasing NAO in the test section was to control the 
amount of narrowing, while keeping the original patient-specific geometry intact.  
This was made possible using the “Inside Hollow” function of the software package 
3-matic (Materialise, Leuven, Belgium). This feature allowed narrowing of the 
intended diameter of the vessel while maintaining the original geometric shape. The 
“Morphing” feature was used to blend the narrowed part to the native upstream and 
downstream sections. Illustration of created NAO is shown in Figure 4.1. 
 64 
 
Figure 4.1. Coarctation (highlighted) added to the original UM5 test section geometry 
using 3-matic. 
In vitro realization of homeostasis: Test Control 
A coarctation affects the resistance of the descending aorta, altering the SVR 
of the circulation. The human body reacts to changes in the circulation by attempting 
to maintain perfusion. This physiological response was realized in vitro by controlling 
Cardiac Output (CO). In experimental tests, after changing the coarctation, the mean 
aortic pressure of the VAD was adjusted to restore the CO to the patient-specific 
baseline value. Mean aortic pressure and the distribution of flows among the upper 
body, lower body, and lungs were allowed to change in response to COA. 
Pressure measurements 
One advantage of an in vitro test bench over a numerical model is the ability 
to mimic certain clinical measurements. Here it was possible to mimic an 
interventional catheter measurement and to compare that measurement to a standard 
engineering wall pressure measurement.  
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In order to measure pressure across a coarctation, two methods were used.  
 In method 1, wall pressure taps were built into the aortic arch and in the 
descending aorta. Using the diameter of the descending aorta at diaphragm as 
dimension D, wall taps were placed at (1) 2.5D upstream of the COA (noted as 
PRE), (2) 1D downstream of COA (noted as 1D), and (3) 10D downstream the 
COA (noted as POS). 
 In method 2, a 2.13 mm diameter catheter (6.4 French) was used to measure the 
pressure at the aforementioned sites: PRE, 1D, and POS in the test sections. 
Pressure gradient was measured in each case using the pullback technique (Baim 
SD, 1991). The sites of measurements are shown in Figure 4.2. 
 
Figure 4.2. (a) Locations of pressure taps added to a patient-specific aortic test-
section with coarctation.  For catheter measurements, the catheter tip was placed on 
the blood vessel axis at the same locations. (b) 3D printed wall tap on descending 
aorta. 
In the catheter pullback technique, the presence of the catheter can partially 
obstruct the COA throat. This blockage causes a rise in ascending aortic pressure and 
an overestimation of the pressure gradient. This is a classical issue. In this study the 
 66 
pressure measurements via wall taps (with the COA unobstructed) were used for 
direct comparison to catheter measurements, to quantify the gradient overestimation.  
However in some of the smallest CoI cases in this study, catheter measurements were 
not possible because the catheter diameter exceeded the coarctation ID. 
Single ventricular power 
Single ventricular power (SVP) is the measure of work delivered by the 
single-ventricle heart to the vascular load. Addition of COA is effectively similar to 
adding extra SVR. The heart, under this circumstance, needs to maintain the same CO 
and oxygen delivery (OD), but aortic pressure is increased, which increases load on 
the ventricle.  
A VAD is used to provide the function of the single ventricle (SV) in the 
mock circulation. The VAD used in this study is a Berlin Heart, driven by 
compressed air (Vukicevic, 2013), as shown in Figure 2.2 and Figure 2.5. The SVP is 
hydraulic power supplied by the VAD to the mock system. In Figure 4.3, Qin and Pin 
denote the inflow volumetric flow rate and pressure into the VAD, and Qout and Pout 
denote the outflow volumetric flow rate and pressure from the VAD. The VAD 
boosts flow from Pin to Pout.  The flow rate delivered varies according to the driving 
air pressure and heart rate, and the mock vascular load. 
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Figure 4.3. A Ventricular Assist Device (VAD). Qin and Qout denote volumetric 
flow rate of inflow and outflow. Pin and Pout denote the pressures of inflow and 
outflow. 
The SVP, which is the time-averaged hydraulic power of the VAD, can be calculated 
based on measurements as below. 
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           (4.1) 
The outlet flow is pulsatile in both pressure and flow rate, so it was measured 
with high temporal resolution, 160 samples/second, and the outlet term of the time 
integral was calculated directly from the data. The inlet flow was at constant pressure 
(atrial pressure in the mock system), so the inlet term of the integral can be calculated 
simply as the product of mean pressure and flow. From the continuity principle, mean 
Qin is equal to mean Qout. 
Global measurements 
Global measurements were conducted using the same method documented in 
section 2. Measurements were conducted in the same sites shown in Figure 2.2, plus 
the additional sites described in this section.   
Results 
In this study, hemodynamics changes in response to CoI change were studied. 
Pressure differentials (pressure differences between two locations) were calculated 
using two methods. In method 1, the pressure difference between the PRE and 1D 
locations was calculated, while in method 2, the pressure difference between the PRE 
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and POS positions was calculated. This procedure was repeated for both wall pressure 
tap measurements and catheterization measurements for each case and each patient. 
Likewise, the peak to peak gradient taken from the time-based wall tap and catheter 
pressure measurements between PRE and 1D was calculated, as was the peak to peak 
pressure gradient between PRE and POS, from wall tap data and again from 
catheterization data.  
Mean flow rate was also calculated from the measurement. Time averaged 
mean flow rates over 25 cycles were calculated at ascending aorta, mBT shunt, upper 
body, and lower body. The pulmonary to systemic ratio Qp/Qs was also calculated for 
each of the cases.  
GOSH22 
GOSH22 has a slight tubular aortic arch. Figure 4.4 shows the hemodynamic 
response of GOSH22 to CoI variation. Mean and systolic pressure gradients were 
measured as described above. In subfigure (a), when CoI >0.5, there is hardly any 
change of mean pressure differential ( 5 mmHg for tap measurement;  10 mmHg 
for catheter measurements). However, when CoI < 0.5, mean pressure differential 
become very sensitive to CoI change. In subfigure (b), for CoI =1 to 0.6, peak to peak 
pressure gradient changed from 0 to about 15 mmHg for both catheter and wall tap 
measurements. However from CoI to 0.6 to 0.4, tap-measured peak to peak gradient 
increased by about 30 mmHg. From catheter measurements, peak to peak gradient 
increased by about 30 mmHg in response to a CoI decrease from 0.5 to 0.4. In 
GOSH22, there is very little difference between PRE-1D measurement and PRE-POS 
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measurements for both tap measurements and catheter measurements. In subfigure (c), 
SVP of GOSH22 showed a different pattern; the response is linear with about 20 mW 
increase. Flow rates are shown in subfigure (d). Ascending aorta flow rate, or CO, 
was held constant. A decrease in lower body flow rate by 0.07 lpm was observed. 
Shunt flow and upper body flow increased as expected, and Qp/Qs ratio was increased.  
 
Figure 4.4.  Measured hemodynamics of GOSH22 case in response to CoI variation: 
(a) mean pressure differential (b) peak to peak pressure gradient, (c) Single Ventricle 
Power, (d) flow rates. 
MUSC2 
The hemodynamic response of MUSC2 to CoI variation is reported in Figure 
4.5. The native neoaortic arch morphology of the MUSC2 was considered “moderate”, 
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neither tubular nor dilated. Patterns observed in GOSH22 also occurred in this patient. 
Overall trends for pressure differential and peak to peak pressure gradients had low 
sensitivity to CoI variation when CoI> 0.4, becoming they are very sensitive to CoI 
change for CoI<0.4. The SVP had hardly any change until CoI =0.43, then from CoI 
=0.43 ~ 0.23, SVP increased about 40 mW. Flow rates are shown in subfigure (d). 
Ascending aorta flow rate, or CO, was held constant. Decrease in lower body flow 
rate was observed. Shunt flow and upper body flow increased as expected, and Qp/Qs 




Figure 4.5. Measured hemodynamics of MUSC2 case in response to CoI variation: (a) 
mean pressure differential (b) peak to peak pressure gradient, (c) Single Ventricle 
Power, (d) flow rates. 
UM5 
The hemodynamics response of UM5 to CoI variation is shown in Figure 4.6. 
UM5 is the case with dilated aortic arch. Visually inspecting subfigure (a) and 
subfigure (b), one can tell that this set of pressure differential and peak to peak 
pressure gradient tracing behave differently from the previous two cases. The 
hemodynamics response to CoI variation is almost linear. This pattern also occurs in 
SVP response and system level flow rate change. Note that the overall increase of 
SVP is comparatively linear relative to the previous two cases. Ascending aorta flow 
rate, or CO, was held constant. Decrease in lower body flow rate by 0.06 lpm was 
observed with a linear response to CoI change. Shunt flow and upper body flow 
increased as expected, and Qp/Qs ratio was increased.  
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Figure 4.6. Measured hemodynamics of UM5 case in response to CoI variation: (a) 
mean pressure differential (b) peak to peak pressure gradient, (c) Single Ventricle 
Power, (d) flow rates. 
UM10 
Figure 4.7 shows the hemodynamic response of the UM10 case to CoI 
variation. UM10 has a dilated neoaortic arch. Due to the native NAO of the patient, 
CoI variation could only be realized from 0.72 to 0.28. Also, due to the narrow 
descending aorta, catheter measurements were not possible for most of the CoI range. 
Hence only wall tap measurements are reported in this case. 
Overall, the pressure differential and peak to peak pressure gradients 
demonstrated a comparatively linear response to CoI variation. The baseline of SVP 
is higher than the other four cases, because of the high MAP and CO of the patient 
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(73mmHg, 1.86 lpm). Flow rate responses are reported in subfigure (d): CO was held 
constant, the mBT shunt flow and upper body flow increased overall, lower body 
decreased, and Qp/Qs increased.  
The changes in flow rates are summarized in Table 4.1. 
 
Figure 4.7. Measured hemodynamics of UM10 case in response to CoI variation: (a) 
mean pressure differential (b) peak to peak pressure gradient, (c) Single Ventricle 







GOSH22 MUSC2 UM5 UM10 
Dilation/Tubular Tubular  Normal Dilated Very dilated 
CoI 0.90~0.30 0.77~0.23 0.95~0.35 0.72~0.28 
CO ± STD 1.86±0.01 1.29±0.01 1.67±0.02 1.87±0.02 
Change in Qub (Lpm) +0.02 +0.06 +0.03 +0.04 
Change Qpul (Lpm) +0.05 +0.08 +0.05 +0.02 
Change Qlb (Lpm) -0.07 -0.15 -0.05 -0.04 
Change in SVP (mW) +23.01 +44.81 +21.76 +24.63 
Change in mean Aorta  
Pressure (mmHg) +5 +15 +3 +5 
Table 4.1. Flow change and ventricular power change over the range of Coarctation 
Index. 
 Discussion 
The study allows some insight into the system-level response to COA in the 
Norwood circulation with mBT shunt. Some general trends can be observed from the 
results. With constant cardiac output (CO) maintained, decreases of lower body flow 
rate were observed as expected, due to the increases of total LBSVR induced by 
narrowed aorta. Shunt and upper body flow rates for all four cases also increased, as 
expected, due to the increase of pressure differences across both branches.  
According to continuity: 
𝐶𝑂 = 𝑄𝑝𝑢𝑙 + 𝑄𝑙𝑏 + 𝑄𝑢𝑏   (4.2) 
Since CO was held constant, the amount of decrease in lower body should be equal to 
the amount of the increase in upper body and mBT shunt combined. That is: 
−∆𝑄𝑙𝑏 = ∆𝑄𝑝𝑢𝑙 + ∆𝑄𝑢𝑏   (4.3) 
Conservation of mass was confirmed to within ±0.03 lpm, well within the 
measurement error.  
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Referring to Table 4.1, changes in pulmonary shunt flow exceeded changes in 
upper body in all cases but UM10. This implies the pulmonary branch is more 
sensitive to coarctation effects than upper body for these cases. This phenomenon is 
expected from a mathematical perspective. For each of the patients, UBSVR is higher 
than PVR + Rshunt. This implies the body flow rate is more sensitive to pressure 
changes than pulmonary flow rate.  
The exception case was UM10 in which the upper body flow rate changed 
about as much as did the pulmonary blood flow. The actual flow change in this case 
was very small (0.04 lpm), and so well within the statistical significance of 
measurement uncertainty.  
Does CoI cause changes in the cardio-shunt flow phase difference? In order to 
answer this question, GOSH22 cardio-shunt flow phase differences are compared in 
Figure 4.8 for CoI=0.9 and CoI=0.3.  
 




In Figure 4.8, as CoI decreases, there is no discernable difference in cardio-shunt phase 
lag between the CoI =0.9 (mild) and CoI=0.3 (severe) scenarios. The same observations 
were reached after examining the other three patient-specific cases.  
 
Figure 4.9. Ensemble lower body flow rate tracing for GOSH22. 
 
Lastly, the ensemble Qlb flow rate curve in Figure 4.9 for CoI=0.9 and 
CoI=0.3 were compared. As COA was progressively added, the average Qlb 
decreased from 0.33 Lpm to 0.26 Lpm and pulsatility became muted. When CoI =0.9, 
the lower body flow rate had noticeable reverse flow, with reverse to forward flow 
ratio of 0.8. This is due to the compliance of descending aorta. Some of the reverse 
flow went to upper body branches and some of the reverse flow went to the 
pulmonary branch, the ratio of which is depended on the UBSVR to PVR+Rshunt ratio. 
In the case of COI=0.3, it was found that reverse flow was eliminated, lower body 



















resistance in the descending aorta. The same conclusions were reached after 
examining the other three patient-specific cases.  
The measured ventricular power (SVP) over CoI for each patient is plotted in 
Figure 4.10(a). The increase in ventricular power due to increasing coarctation 
severity relative to the baseline coarctation was minimal for all cases between CoI = 
1.0 to 0.5. This would indicate that coarctation severity is too modest to affect the 
single ventricle power. However, when coarctation severity progressively increased 
(CoI < 0.5), a noticeable increase in SVP was observed. This extra power load on the 
delicate single ventricle may indicate the need for intervention to relieve the 
coarctation.  
From the SVP curves of Figure 4.10a, MUSC2 (Normal arch dilation) has the 
lowest SVP required, while the more tubular one (GOSH22) and the more dilated 
ones (UM5 and UM10) have higher SVP requirements. An abnormal arch 
morphology can act as a form of extra resistance to the system, as noted here.  For the 
four cases studied, aortic arch morphology affects single ventricle power 
requirements (p < 0.05) and this is sensitive to CoI. 
This effect of CoI on single ventricle power can be highlighted by studying 





    (4.4) 
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The sensitivity was calculated using a central differencing scheme except at the end-
points where forward or backwards differecing was used. For central differencing, S was 




  (4.5) 




  (4.6) 




  (4.7) 
Figure 4.10 (b) plots Ssvp vs. CoI of all four cases. Sensitivity is near zero for 
all cases as CoI > 0.5. The sudden increase in sensitivity is clear for CoI < 0.5 and 
particularly as CoI is decreased further (more severe). This illustrates the nonlinear 
response of SVP change to CoI, and shows that the single ventricle power 
requirements significantly increase only when coarctation reaches severe stages, such 
as below CoI < 0.5.  
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Figure 4.10. Scatter plot of (a) SVP vs. CoI and (b) Ssvp against CoI for all four cases. 
In order to quantify when statistically significant occurs, piecewise regression 
was conducted using SVP data. Piecewise regression partitions CoI into several 
separated intervals and fits a separate linear regression model to each interval of CoI. 
Piecewise analysis result in Figure 4.16 shows that breakpoint in the case GOSH22 is 
CoI=0.4, for MUSC2 are CoI=0.46 and 0.28, for UM5 is CoI= 0.49, and for UM10 is 
CoI=0.37.  Overall, the results suggests that breakpoint for four five cases occurs 
when CoI<0.5. This is when statistically significant changes occur.  
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Figure 4.11. Piecewise regression results for five cases’ SVP data, with estimated 
breakpoints and R2 indicating the goodness of fit. 
Figure 4.12 (a) illustrates Pre- to Post- mean pressure difference as measured 
by pressure tap. It can be seen from Figure 4.12 (a) that mean pressure differences are 
very similar for all for cases from CoI=0.35 to 1. When CoI dropped below 0.35, 
GOSH22 is 7 mmHg higher than UM10 and MUSC2. Again, define a sensitivity as 
 𝑆𝑝𝑚 =
𝑑 mean difference 
𝑑 𝐶𝑜𝐼
    (4.8) 
As illustrated in Figure 4.12 (b), the behavior is similar to that of SVP. From CoI = 
1.0 to 0.5, Ssvp data points scatter about 0, indicating no significant mean pressure 
difference change. When the CoI dropped below 0.4, the mean pressure difference 
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became increasingly sensitive to the CoI. Overall, the sensitivity responses are very 
similar for each patient; this could be an important clinical indication that CoI =0.5 is 
a threshold below which the mean pressure difference becomes significant for 
progressing coarctation.  
 
Figure 4.12. Scatter plot of (a) mean pressure difference vs. CoI and (b) Spm against 
CoI for all four cases. 
 
The aortic arch morphology differs for each patient. It can be concluded from 
the analyses of SVP and mean pressure difference alone, that aortic arch morphology 
should not be expected to reveal obvious differences in hemodynamics responses.  
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In addition to SVP and mean pressure difference, there are two other 
parameters that are of clinical interest. They are Qp/Qs and peak to peak pressure 
gradient. Figure 4.13 (a) illustrates peak to peak pressure gradient changes with CoI 
for all four patients. Overall, the pressure gradients increase gradually as CoI is 
decreased. When CoI falls below 0.5, the relative change in the pressure gradient 
increases. This can be better seen quantitatively through the peak to peak pressure 
gradient sensitivity, defined as 
𝑆𝑝𝑔 =
𝑑 ∆𝑝𝑒𝑎𝑘 𝑡𝑜 𝑝𝑒𝑎𝑘 𝑔𝑟𝑎𝑑𝑖𝑒𝑛𝑡
𝑑 𝐶𝑜𝐼
     (4.9) 
and plotted in Figure 4.13 (b). There is a noticeable change in the sensitivity for CoI < 
0.5. All four cases demonstrate similar behavior, with no discernable difference 
among the four patients studied.  
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Figure 4.13. Scatter plot of (a) peak to peak pressure gradient vs. CoI and (b) Spg 
against CoI for all four cases. 
 
The peak to peak pressure gradient data indicates that it is less sensitive to 
changes in CoI than SVP or mean pressure gradient. Peak-to-peak gradient data are 
used clinically. The differences may be answered by examining the pressure 
waveform at “Pre” and “Post” wall tap site, as shown in Figure 4.14.  
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Figure 4.14. Ensemble pressure tracings at (a) Pre measure site (b) Post measure site. 
 
 From Figure 4.14, it can be seen that there are two effects coming into play 
here, one is the change in mean, this effect impacts peak to peak gradient like a 
baseline shifting. The other effect is the damping of Ppost amplitude, directly 
increasing the gradient.  This is due to the Coarctation resistance Rcoa and 
downstream compliance Clb work together as a RC filter, and as Rcoa increases, the 
filtering effect becomes stronger. The damping effect begins immediately, even for 
small values of Rcoa, whereas the mean value is reduced only as Rcoa becomes 
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significant relative to Rlb. These two effects work together so the peak to peak 
gradient response is more linear than SVP and mean pressure responses.  
 Qp/Qs data can be examined in Figure 4.17 (a). There is a discernable 
difference in the achieved ratio for each patient. This would be a consequence of their 




     (4.10) 
as the sensitivity of Qp/Qs to CoI. This is plotted in Figure 4.17 (b). Between 0.6 < 
CoI <1 the change in Qp/Qs with CoI is minimal.  Below CoI < 0.5, Qp/Qs becomes 
more sensitive to CoI change. This can be quantitatively confirmed by the sensitivity 
plot in Figure 4.17(b). The rate of change in flow distribution Qp/Qs to CoI increases 
noticeably below CoI < 0.5. This indicates that CoI <0.5 may indicate a state where 
clinical intervention should be considered. The Qp/Qs versus CoI measurements for 
all four cases demonstrate a similar behavior in that the Qp/Qs balance of the native 
condition becomes affected only at severe CoI.  
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Figure 4.15. Scatter plot of (a) Qp/Qs vs. CoI and (b) Sratio against CoI for all four 
cases. 
 
There exists the potential for arch morphology to affect the phase of shunt 
flow. Specifically, it was investigated if the cardiac cycle phase with shunt flow rate 
is different among four patients. Figure 4.16 shows relative phase difference between 
cardiac cycle and shunt flow rate for the four cases. It can be concluded from Figure 
4.16 that there is no discernable difference of cardiac-shunt flow phase difference 
among the four cases. In all four cases, shunt flow rates have no retrograde flow, and 
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peak of shunt flow rates occurred just a little before VAD valve closure. Hence aortic 
morphology does not have an effect on cardiac-shunt flow phase for these patients. 
Figure 4.16. Ascending aortic flow rate and shunt flow rate in (a) GOSH22 (b) 
MUSC2 (c) UM5 (d) UM10. 
 
From the foregoing analysis, aortic arch morphology affected SVP. Abnormal 
shapes (tubular or dilated) required increases in ventricular power from a normal 
shape.   
Comparisons with Previous Work 
These results confirmed some observations made in previous studies. Overall, 
the tests indicated that the pressure difference response to CoI severity was non-linear, 
which was also reported by Engvall et al. (Engvall, 1991). From an engineering point-
of-view, the pressure difference across an obstruction, such as an orifice, is non-linear 
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with obstruction diameter. What this study here shows is the systems-level response 
to CoI severity. 
 
Figure 4.17. Volume distribution variations (%) for the three anatomical models, with 
the amount to the lower body being reduced with the presence and increased severity 
of coarctation. Volumes to each lumped vascular bed (upper body, lower body, and 
shunt) are also reported in ml on the graph bars. (Biglino, 2012) 
 
Decrease in Qlb, increase in both Qub and Qpul and overall increased Qp/Qs 
were observed as COA narrows, which was also reported by Corsini et al. (Corsini, 
2014). Figure 4.17 illustrates results in a study conducted by Biglino’s group. Biglino 
et al’s result confirmed results in this study that COA causes Qlb decrease, Qub 
increase. However Qshunt trend is not clear in their study, it increased in the case 
moderate coarctation, but decreased in the case severe coarctation.  This counter-
intuitive result can be attributed to the fact that author claimed their Qp/Qs is not 
physiological.    
 Overestimation of pressure gradient caused by COA due to pressure recovery 
was reported by Giardini et al. (Giardini, 2010). Defining Error = (SBE predicted 
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/actual gradient -1)×100, Giardini et al demonstrated the Error vs. Reynolds number 
(Re) relationship, using 3 different simplified Bernoulli equations in Figure 4.18. 
Figure 4.18 shows when Re is low, error is minimal, error increases as Re increases 
till Re=4000. Then Error decreases as Re continuously increases. Compare with 
results in this study, it was possible to measure pressure recovery in some specific 
patients at specific CoI. In this case, define Error = (Pre-1D gradient/ Pre-Post 
gradient -1) ×100, which is comparable to the scenario 𝐷𝑃𝐺 = 4((𝑉2)
2 − (𝑉1)
2) in 
Figure 4.18 (grey dots). The maximum error is 20%, with the maximum Re 1000. 
These observations echo with the Giardini results. 
 
Figure 4.18: The relationship between Reynolds number and Doppler/Actual percent 
error using the simplified Bernoulli equation, the extended Bernoulli equation and 
considering pressure recovery effects. (Giardini, 2009) 
 
Table 4.1 revealed an unexpected phenomenon regarding an ascending aortic 
pressure increase. How much ascending aortic pressure increase should be expected 
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as coarctation develops? One animal study conducted on biventricular dogs indicated 
that from “Normal” to CoI=0.3, mean ascending aortic pressure increased around 37 
mmHg (Gupta, 1951).  However, this study suggests that for a univentricular 
Norwood patient with mBT shunt, the situation is quite different. The data here show 
around a 5 mmHg increase from 1 < CoI <0.3. Even when CoI narrowed to 0.23, the 
highest pressure increase in ascending aorta observed was 15mmHg.  Such small 
ascending aortic pressure increase was not expected.  
The reason why there is such a different result is twofold. First, Norwood 
circulation is categorically different from normal biventricular circulation. The added 
pulmonary flow, roughly equal to the total systemic flow and competing directly with 
the lower body flow, greatly reduces the sensitivity of the system to throttled lower 
body flow. The mBT shunt is like a bypass, relieving pressure increase in the aortic 
arch. Second, the MCS uses a VAD, which is different from a natural ventricle in its 
performance. Cardiac output and heart rate were deliberately maintained constant in 
this study;  in practice, CO and HR may behave differently as developing coarctation 
changes both preload and afterload and the body responds to maintain oxygen 
delivery. However, it remains unclear if the pattern observed would be different. The 
relationship between Reynolds number and Doppler/actual percent error using the 
simplified Bernoulli equation, the extended Bernoulli equation, and considering 
pressure recovery effects. The relationship between Reynolds number and 
Doppler/actual percent error using the simplified Bernoulli equation, the extended 
Bernoulli equation, and considering pressure recovery effects. 
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Regarding the effect of transverse aortic arch morphology on hemodynamics 
response, one possible conclusion is that transverse arch and isthmus hypoplasia does 
not affect hemodynamics response due to COA. Ntsinjana et al pointed out that it is 
the transverse arch and isthmus hypoplasia, rather than acute arch angulation, plays a 
role in the pathophysiology of BP response to peak exercise following CoA repair 
(Ntsinjana, 2013). In this study, it was also concluded that aortic arch dilation affects 
hemodynamics response.   
More importantly, this study revealed many phenomena that have not been 
produced before. Previous COA studies are mostly in the context of biventricular 
circulation, but this study of COA in the context of univentricular circulation 
(Norwood Circulation) in particular breaks new ground.   
Secondly, most of the early COA studies have used generic aortic phantoms 
with an idealized coarctation profile. Norwood patients have a wide spectrum of 
aortic morphology, which could contribute to various fluid dynamics phenomena in 
the aorta. Using a generic aortic phantom with idealized coarctation profile is not 
sufficient to study this morphological effect. The model described here used a 
sampling of patients with a range of realistic aortic morphologies, while also keeping 
the native geometrical profile at COA site while decreasing its diameter. This strategy 
permitted investigation of differences from patient to patient.  
Thirdly, this study investigated COA’s effect on global hemodynamics. In 
most of the previous studies, adopted cfd model of a generic aorta domain was used 
with boundary conditions prescribed at inlet and outlets and the effect of progressive 
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COA narrowing within this domain was studied. There is no coupling with the entire 
circulation. There are very impressive studies conducted using this approach, such as 
LaDisa et al 2011. However, as discussed in section 3.2, using this method does not 
allow investigating the effect of COA on global hemodynamics. The multiscale MCS 
presented in this study allows studies into how the progressive coarctation impacts the 
lower body flow rate, distribution of flows to the various territories, PA pressure, and 
other variables.  
Lastly, the reason why COA is especially harmful to the Norwood patient is 
because it adds an extra work burden to the already overloaded single ventricle. Due 
to the hemostasis process, the single ventricle works even harder to maintain CO in 
spite of COA. This process was approximated in this study by maintaining CO 
constant as coarctation severity was increased. This enabled a means to quantify the 
hydraulic workload, which is especially important to Norwood patients. The final aim 
is to provide guidance to the clinical professional on when surgical intervention is 




IN VITRO MULTI-SCALE PATIENT-SPECIFIC STUDY OF COARCTATION 
IN NORWOOD PATIENTS WITH A RIGHT VENTRICLE SHUNT (RVS) 
RESULTS 
 
The modified BT shunt (mBT) and the right ventricular (Sano) shunt (RVS) 
are two of the most prevalent options in the Norwood procedure. There has been no 
study that directly compares RVS and mBT potential performance on the patient-
specific level in the context of recurring neoaortic coarctation (NAO). It is still 
unknown which one of the two surgical options is more sensitive to NAO narrowing, 
and if  there is any difference with regard to hemodynamic response? The MCS 
provides a means to assess any differences and perhaps delineate their causes. The 
goal of this part of the study is to improve the understanding of the differences 
between the RVS and mBT in a NAO context by direct comparison. An outcome 
would be to reveal which type of circulation is more sensitive to NAO, and identify 
the difference in hemodynamic response as NAO develops. To accomplish this, the 




This is an in vitro study of hemodynamics in Stage 1 Norwood patients with a 
ventricular-to-pulmonary RVS. The previously described MCS was modified to 
 94 
model the the SVS circulation (Biglino, 2013).  Using rapid manufacturing 
techniques, patient-specific test models of the neoaorta were constructed. For each 
patient model, the severity of coarctation was increased using separate test sections. 
Selection of patients 
Patients selected in this study are GOSH22, MUSC2, UM5, and UM10. 
Patient parameters were given previously in Figure 2.2 and Table 2.1.  
Mock Circulatory Design 
Certain modifications were necessary to complete the RVS mock circulatory 
design, as shown in the layout of Figure 5.1. In particular, the RVS (shunt) was 
connected directly to the lumen of the VAD. The de-airing valve located on the 
liquid-side chamber of the VAD was selected as the site having the best structural 
support. The de-airing valve was hollowed out to create a 5 mm outflow port, and a 
Tygon tube was connected from there to the pulmonary circulation, at the compliance 
chamber, thus completing the RVS. The same test sections used previously were used 
here, but with the mBT shunt blocked off. Because the mBT shunt nub on these 
models is located downstream in the brachiocephalic artery, the stagnant zone in the 
nub should not affect hemodynamics in the aortic arch. .  
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Figure 5.1 Reduced Lumped parameter network model used for mock circulatory 
system in RVS setup with measurements points shown. R, resistance; C, compliance; 
P, pressure; Q, flow rate; C.O., Cardio output; Asc.Ao, Ascending aorta; Prox, 
proximal; pul, pulmonary shunt; d, descending aorta; atrium, atrium; bc, 
brachiocephalic artery; lcc, left common carotid artery; lsc, left subclavian artery. 
 
In vitro realization of homeostasis 
As described in section 4.2, the human body reacts to changes of circulation 
by attempting to maintain perfusion. This physiological response was realized in vitro 
by controlling the cardiac output (CO), which was maintained constant. The mock 
circulatory system was first tuned using the parameters of Table 1.1 for a given 
patient in mBT circulation. Then, after changing the coarctation, the driving pressure 
of the VAD was adjusted to restore the CO to the baseline value. Mean aortic 
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pressure and the distribution of flows among the upper body, lower body, and lungs 
were allowed to change in response to COA. When the system was converted to RVS 
circulation all the system parameters exclusive of the mBT shunt were kept the same, 
so a different baseline pulmonary flow (Qp) and CO were allowed. As the coarctation 
was changed, the VAD was adjusted again to maintain the value of CO for RVS. 
Single ventricular power 
Single ventricular power (SVP) was measured in a different manner with the 
RVS setup. Figure 5.2 shows the schematic of the VAD in RVS circulation. The 
VAD has two outflows as opposed to one outflow in the mBT setup. Qin and Pin 
denote the inlet flow and pressure, with inlet pressure taken as equal to atrium 
pressure. For the outflows, Pout denotes the liquid side pressure of the VAD, which is 
the driving pressure for both pulmonary and systemic circulations. Qout1 and Qout2 
denote systemic flow and pulmonary flow respectively. The formula to calculate VP 
in a RVS setup is:  
1 2
1




       (5.1) 
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Figure 5.2. A Ventricular Assist Device (VAD) diagram, Qin Qout1 and Qout2 
denote volumetric flow rate of inflow, systemic and pulmonary circulation outflow, 
Pin Pout denote flow pressure of inflow and outflow. 
Due to the nature of RVS flow, regurgitation fraction was calculated using the time-
based RVS flow rate data and the following equation: 
𝑅𝐹 = [%] =
𝑄𝑟𝑒𝑣𝑒𝑟𝑠𝑒
𝑄𝑓𝑜𝑟𝑤𝑎𝑟𝑑
× 100 (5.2) 
Results 
The experiments were designed to measure systems-level hemodynamics 
changes in response to increasing coarctation severity in the RVS circulation. From 
these results, a comparison to the mBT procedure was made. 
Mean pressure differences were calculated using two methods. In method 1, 
mean pressure differences between PRE and 1D were calculated, while in method 2, 
mean pressure difference between PRE and POS were calculated. Also, peak pressure 
gradients were calculated using the same methods. 
Mean flows were also measured. Time-averaged mean flows were calculated 
at ascending aorta, mBT shunt, upper body, and lower body. For the ease of 
comparison, flows are presented as the percentage of the total flow or systemic flow. 
The pulmonary to systemic ratio Qp/Qs was also calculated for each of the cases.  
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GOSH22 
GOSH22 had a slight tubular aortic arch. Figure 5.3(a) shows the mean 
pressure difference response vs. CoI. In the RVS scenario, the pressure difference is 5 
mmHg or less from CoI=0.9 to 0.5. From CoI=0.5 to 0.3, pressure difference 
increased to over 20 mmHg. The overall pressure difference response to CoI change 
demonstrates an exponential-like curve. There is no significant difference between 
RVS and mBT here. Similarly in Figure 5.3(b), peak pressure gradients demonstrate a 
similar non-linear response, that is, pressure gradient is more sensitive to CoI change 
at low CoI.  Small difference are observed between RVS and mBT pressure gradient. 
RVS pressure gradients are higher than the mBT counterparts from CoI=1 to CoI=0.5, 
by 8mmHg maximum. From CoI =0.3 down to CoI=0.1, mBT pressure gradients are 
higher than the RVS counterparts by up to 5 mmHg.  
Figure 5.3(c) shows the SVP response. Overall there is no significant change 
in SVP from CoI = 0.9 to 0.6. From CoI =0.6 to 0.3, SVP of each increased by 22mW. 
There is a systemic reduction (25mW) of RVS vs. mBT SVP, mainly due to the lower 
Qp of the RVS. 
Figure 5.3(d) shows the flow changes in both cases. Total flow (CO) for each 
case was held constant as CoI was reduced. Note that RVS has less CO than mBT, 
due to reduced pulmonary flow. With a generic 5 mm diameter ventriculotomy and 5 
mm RVS shunt size, shunt flow was 0.67 lpm which yields a Qp/Qs ratio of 0.8. The 
reason is that this is a physiologically realistic condition. Pulmonary flows (Qp) are 
presented as a percentage to CO. RVS Qp to CO ratio had negligible changes (<0.01) 
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as CoI=0.9~0.3, while the mBT counterpart increased by 0.03. Qub/Qsys increased 
0.05 from CoI =0.9 to 0.3. Qlb/Qsys decreased 0.04 from CoI =0.9 to 0.3. Differences 
in Qub/Qsys and Qlb/Qsys between RVS and mBT were negligible. 
Figure 5.3. Measured hemodynamics of GOSH22 case in response to CoI variation: 
(a) mean pressure differential (b) peak to peak pressure gradient, (c) Single Ventricle 
Power, (d) flow rates. 
MSUC2 
MUSC2 had a normal tubular aortic arch, as shown in Figure 5.4(b). This 
patient’s left subclavian artery was removed during the Norwood surgery.  
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Figure 5.4 (a) illustrates the mean pressure difference response. In the RVS 
scenario, the pressure difference is less than 10 mmHg for CoI=0.78 to 0.35, with a 
linear shape. Pressure difference increases dramatically from CoI =0.35 to 0.23, rising 
to around 50 mmHg with a highly non-linear response. In Figure 5.4(b) pressure 
gradients demonstrate a more consistently exponential-like response, that is, pressure 
gradient is more sensitive to CoI change at lower CoI. Difference between RVS and 
mBT responses is minimal, with almost no difference for CoI >0.35. Less than 10 
mmHg of difference between shunt types was observed for CoI <0.35, and no more 
than 15 mmHg difference for intermediate CoI.  
The nonlinear response was also observed in ventricular work, Figure 5.4 (c). 
There is a systemic difference between the two responses, but unlike GOSH22, it is 
not explained by a proportionate reduction of Qp. Instead, this reveals improved 
efficiency of the RVS, due to some shunt flow continuing during diastole, at lower 
ventricular pressure. Both RVS and mBT SVP increase significantly only for 
CoI<0.35.  
Figure 5.4 (d) shows the volumetric flow changes in both cases. CO for each 
case was held constant at the initial value for CoI=0.78. Overall the flows responded 
similarly to GOSH22. In both mBT and RVS, Qpul/CO increased, Qub/Qsys increased, 
and Qlb/Qsys decreased, all becoming significant only in the lower CoI values.  In 
terms of Qp/Qs, there was a divergence between RVS and mBT in the lower CoI 
values, with a maximum difference of about 0.1 from CoI=0.35 ~0.27. The same 
phenomenon occurs in subfigure (b), RVS peak to peak pressure gradient responses 
demonstrates an exponential shape. From CoI=0.78 to 0.35, there is a pressure 
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gradient around 25 mmHg. From CoI =0.35 to 0.23, pressure gradient increases by 45 
mmHg. Overall the differences between RVS and mBT pressure gradient response 
are very minimal (<7mmHg). With the only exception of from CoI=0.6~0.35, mBT 
pre-1D gradient is lower than RVS counterpart by around 10mmHg. 
The exponential like response is also observed in subfigure (c). Like the 
previous case, there is systemic difference between the two responses because of the 
difference in CO. Besides that, both RVS and mBT SVP responses increases 
noticeably only after CoI<0.35.  
Subfigure (d) illustrates the volumetric flow rate changes in both cases. Total 
flow for both cases were held at constant. Due to the same reason stated in the 
previous case, there is difference in CO. Overall the flow rates responses are very 
similar as in the previous case. In both mBT and RVS, Qpul/CO increased slightly 
especially at lower CoI region, Qub/Qsys increases by a more noticeable value at lower 
CoI region, and Qlb/Qsys decreases by a noticeable amount at lower CoI region. 
Overall Qp/Qs increases noticeably at lower CoI region, and difference around 0.1 is 
observed between the RVS and mBT from CoI=0.35 ~0.27.  
  
 102 
























































   
      
Figure 5.4. Measured hemodynamics of GOSH22 case in response to CoI variation: 
(a) mean pressure differential (b) peak to peak pressure gradient, (c) Single Ventricle 
Power, (d) flow rates. 
UM5 
UM5 had a dilated aortic arch. In Figures 33 (a) and 33 (b), pressure response to 
CoI is more linear, in contrast to the previous two cases. Although both demonstrate 
linear shape, mBT and RVS pressure differences show a noticeable divergence when 
CoI<0.6, and this difference increased as CoI decreased. The same pattern occurs in 
pressure gradient response, and in mBT the peak pressure gradient increased about 
28mmHg overall. 
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SVP did behave similarly to the preceding cases, increasing significantly only at 
the smallest CoI=0.35.  The RVS required much less power than the mBT, and the 
difference is only partly attributable to the lower CO in the RVS sequence. 
In Figure 5.5 (d), Qpul/CO increased slightly as CoI decreased. Qub/Qsys increased 
by noticeable amount and Qlb/Qsys decreased by a noticeable amount, both in a linear 
fashion.  Differences between the RVS and mBT flows were minimal. 
 
Figure 5.5. Measured hemodynamics of UM5 case in response to CoI variation: (a) mean 




UM10 had a dilated aortic arch. Due to the native NAO of the patient, CoI 
variation could only be realized from 0.72 to 0.28. Figure 5.6 shows the hemodynamic 
responses of UM10 to CoI variation. 
From Figure 5.6 (a), it can be seen that both the mBT and RVS cases show a 
linear response of pressure difference to CoI. The differences between RVS and mBT are 
within 6 mmHg. The same trend was observed in pressure gradient responses in Figure 
5.6(b), where the maximum difference between the two cases is 9 mmHg. 
Figure 5.6(c) describes the ventricular power. Both cases remain nearly constant, 
except power of mBT increases only at smallest CoI=0.28. The large systemic difference 
between the two cases can only partly be explained by the difference in CO. 
In Figure 5.6 (d) flow changes are linear, and Qub and Qlb show no differences 
between mBT and RVS, except at CoI=0.23 where RVS has a higher Qlb/Qsys and a lower 
Qub\Qsys. In this case the original patient-specific Qp/Qs was excessive. 
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Overall responses of the four cases are summarized Table 5.1. 
Figure 5.6. Measured hemodynamics of UM10 case in response to CoI variation: (a) 
mean pressure differential (b) peak to peak pressure gradient, (c) Single Ventricle Power, 
(d) flow rates. 
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  GOSH22 MUSC2 UM5 UM10 
Dilation/Tubular Tubular  Normal Dilated Very dilated 
CoI 0.90~0.30 0.77~0.23 0.95~0.35 0.72~0.28 
 mBT RVS mBT RVS mBT RVS mBT RVS 















Change in Qub/Qsys  +0.07 +0.07 +0.19 +0.15 +0.05 +0.05 +0.05 +0.02 
Change Qlb/Qsys -0.07 -0.05 -0.19 -0.15 -0.05 -0.05 -0.05 -0.02 
Change Qpul/CO +0.02 <0.01 +0.07 +0.04 +0.02 +0.02 <0.01 +0.02 
Change in SVP (mW) +23.01 +29.30 +44.81 +35.00 +21.76 +14.04 +24.63 +12.55 
Change in Qp/Qs +0.15 <0.01 +0.30 +0.24 +0.04 +0.03 +0.01 +0.05 
Change in Pasc.ao (mmHg) +5 +10 +15 +12 +3 +7 +5 +4 
Change in Pventricle 
(mmHg) 
NA +1 NA +2 NA +1 NA +1 
Table 5.1. Flow rates, SVP and pressure changes in four patients.  
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Discussion 
The noticeable difference between the systems-level response of the RVS and 
mBT lies within the pulmonary flow. In Figure 5.7, the case GOSH22 CoI=0.9 is 
used to illustrate this difference from the flow perspective. Figure 5.7 (a) shows the 
ascending aortic flow and shunt flow in the RVS scenario. The ascending aortic flow 
and RVS shunt flow occur concurrently. There is a considerable proportion of 
pulmonary retrograde flow during diastole, so the RF is 39%. In Figure 5.7 (b), the 
mBT shunt scenario, there is a phase lag between the ascending aortic flow and the 
mBT shunt flow, with the peak of mBT shunt flow occurring just before aortic valve 
closure. Pulmonary flow is always antegrade in the mBT shunt.  The reasons are 
known and clear: the right ventricle pressure falls below the aortic pressure during 
diastole in the RVS, whereas the aortic pressure remains above the pulmonary 





Figure 5.7. Three seconds of instantaneous flow measurements of (a) GOSH22 CoI=0.9 
with a RVS. (b) GOSH22 CoI=0.9 with an mBT shunt. 
Next, examining the flow responses for all four RVS cases (Figures 5.3-5.6, 
and Table 5.1), as coarctation narrows (CoI decreases), decreases in Qlb were 
observed as expected, due to increasing coarctation gradient in series with the 
constant LBSVR. With reduced Qlb, the VAD was adjusted to maintain CO, 
increasing aortic pressure. This increased Qub, as expected. The changes in Qlb/Qsys 
and Qub/Qsys were very similar between RVS and mBT cases.  
As the VAD was adjusted to higher aortic pressure, the mean ventricular 
pressure also increased, hence increasing the RVS shunt flow. Qpul/CO changes in 
RVS were lower than those of mBT for GOSH22 (tubular arch) and MUSC2 (normal 
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arch). However in the cases of UM5 and UM10 (dilated arch), Qpul/CO changes in 
RVS and mBT were very similar in magnitude.  
Overall, the pulmonary to systemic flow ratio (Qp/Qs) increased for all four 
cases. Changes in Qp/Qs are smaller in RVS cases than mBT except in UM10.  Also 
noteworthy in GOSH22 and UM10, the mBT Qp/Qs ratios are high, meaning there 
was excessive pulmonary flow. Applying an RVS brought down Qp/Qs ratio of these 
two cases closer to unity. While the RVS scenarios are less sensitive to changes in 
COA than the mBT scenarios, the differences are marginal and likely not clinically 
significant..  
Why do systemic flows in the mBT and RVS behave similarly while 
pulmonary flows show significant differences?  Referring to Table 5.1, the difference 
in Pasc.ao between the two cases is not significant (<5mmHg), so the pressure 
differences driving flow through the systemic branches are very similar for all these 




   (5.3) 




  (5.4) 
The RRVS+PVR < RmBT+PVR because the RVS diameter is larger than mBT diameter 
by almost 50%. Because CO was maintained constant, aortic pressure increased with 
coarctation severity. As CoI narrowed, it was observed that Δ (Pasc.ao-Patr) >Δ 
(Pventricle-Patr). So, the mBT cases generally saw a greater change of driving pressure, 
 110 
while RVS was more sensitive due to lower total resistance.  Both effects contributed 
to changes in Qpul, and depending on which effect was stronger, pulmonary flow rate 
changes in RVS could be higher, lower or equal to those in mBT. 
The SVP response to CoI with the RVS indicated a similar behavior as those 
with mBT. The SVP required did not change significantly until CoI was severe.  
However, the SVP with RVS requirements for each patient were generally lower than 
those SVP values measured with the mBT and by 74.5 mW on average. The reason 
why RVS baseline was lower is twofold. First, the shunt is larger in all cases: a 5 mm 
diameter RVS connected the VAD to pulmonary chamber in all four cases (RVS 
cases are extrapolative rather than patient-specific in this respect). The resulting 
baseline Qp was reduced in three cases, with the exception of MUSC2. Since SVP 
depends upon total flow, the effect of reduced Qp reduces the SVP baseline. Secondly, 
from the perspective of pressure, with an mBT shunt, the single ventricle has to pump 
blood to the higher pressure of the systemic circulation. While with a RVS, 
ventricular flow can be pumped directly to pulmonary arteries, which have lower 
pressure than systemic system. These two effects work together, hence SVP baselines 
with RVS are generally lower than those with mBT shunt. This phenomenon was also 
observed in previous studies. In 2001, Shimizu et al. together with Dr. Shunji Sano 
conducted a 0D simulation study comparing mBT and RVS. One important 
observation they made is that RVS is associated with lower ventricular power. 
Shimizu et al claimed that this phenomenon is consistent with clinical observation, 
(Shimizu S, 2011). Also due to the same reason, from Table 2.2, the SVP changes in 
most RVS cases with CoI are smaller than those with mBT shunt except GOSH22. 
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Overall, the SVP change with RVS is less than that with mBT, by 5.8 mW on average 
for the cases studied. 
From a hemodynamics-only view point, the RVS is a better option for some 
cases but any such difference is minimal, because the sensitivity of either circulation 
type to coarctation is similar. While the advantages may be statistically different, the 
difference is very small.  
When looking at morphological differences in the Sano procedure, four 
parameters of clinical interests are examined similar to those studied with the mBT.    
Figure 5.8 (a) plots the SVP changes with coarctation SVP does not change 
much in response to CoI between 0.4 < CoI < 1. For all cases, the change is less than 
15 mW. Below CoI < 0.4, the increase in SVP becomes increasingly greater. The 
aortic arch morphological affects the SVP baselines in this study. It can be seen from 
Figure 5.8 (a) that GOSH22 (tubular) has the highest SVP requirements. MUSC2 
(normal) has the second highest SVP. UM5 is (dilated) about same as MUSC2. 
UM10 SVP (strongly dilated) is lower than MUSC2 SVP. This pattern indicates that 
with an RVS, it is possible that tubular arch morphology is associated with higher 
SVP while dilated aortic arch is associated with lower SVP. 




    (5.5) 
From Figure 5.8 (b), the increased sensitivity to CoI is noticeable for CoI < 0.5. In 
comparison with the results of the mBT shunt, the trend behaviors are quite similar.  
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This is a strong implication that regardless with which shunt configuration, the region 
of CoI < 0.5 is of clinical concern. 
 
Figure 5.8. (a) SVP versus CoI scatter plot of all four cases. (b) Ssvp of all four cases 
against CoI. 
In order to quantify when statistically significant occurs, piecewise regression 
was conducted on SVP data. Piecewise regression partitions CoI into several 
separated intervals and fits a separate linear regression model to each interval of CoI. 
Piecewise analysis results in Figure 5.9 shows that breakpoint in the case GOSH22 is 
CoI=0.6, for MUSC2 are CoI= 0.3, for UM5 is CoI= 0.42, and piecewise regression 
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was not applicable for UM10.  Overall, the results suggests that breakpoint for four 
five cases occurs when CoI<0.6. This is when statistically significant changes occur.  
 
 
Figure 5.9. Piecewise regression results for five cases’ SVP data, with estimated 
breakpoints and R2 indicating the goodness of fit. 
Figure 5.10 (a) illustrates the Qp/Qs response to CoI. There is little change 
between 0.4 < CoI < 1. For CoI < 0.4, the change becomes increasingly greater and 
nonlinear. This can be quantitatively confirmed by plotting the sensitivity, as shown 




   (5.6) 
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 The rate of change becomes noticeably significant for CoI < 0.4. Similarly, it can be 
seen that all four cases demonstrated similar behavior, with no discernable difference 
among four cases. In the RVS, the Qp/Qs change occurs closer to 0.4 than with the 
mBT, which noticed the change closer to 0.5. The difference is subtle and well within 
experimental error.  
 
Figure 5.10: Scatter plot of (a) Qp/Qs vs. CoI and (b) Sratio against CoI for all 
four cases. 
Figure 5.11(a) illustrates Pre- to Post- mean pressure difference measured 
using wall taps. In Figure 5.11 (a), mean pressure difference tendencies are very 
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similar but there are differences between morphologies. There is little change 
between 0.4 < CoI < 1. When CoI dropped below 0.4, GOSH22 was 9 mmHg higher 
than UM10 and MUSC2.  
Define the sensitivity,  
𝑆𝑝𝑚 =
𝑑 mean difference 
𝑑 𝐶𝑜𝐼
   (5.7) 
As shown in Figure 5.11(b), there is little change in sensitivity above CoI > 0.4. 
Below CoI < 0.4, sensitivity progressively increased. The trend behavior between the 
RVS and mBT procedures show little difference in response to coarctation.  
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Figure 5.11. Scatter plot of (a) mean pressure difference vs. CoI and (b) Spm against 
CoI for all four cases. 
 
Figure 5.12 (a) illustrates the peak to peak pressure gradients response to CoI 
for all four patients with RVS. Overall the pressure gradient responses demonstrate 
more comparatively linear behavior than the SVP and mean pressure difference, as 
noted in the mBT. There is a gradual increase in pressure with CoI. Define the peak to 
peak pressure gradient sensitivity as 
𝑆𝑝𝑔 =
𝑑 ∆𝑝𝑒𝑎𝑘 𝑡𝑜 𝑝𝑒𝑎𝑘 𝑔𝑟𝑎𝑑𝑖𝑒𝑛𝑡
𝑑 𝐶𝑜𝐼
   (5.8) 
 This is plotted in Figure 5.12 (b). The sensitivity changes noticeably around 
CoI = 0.5 and markedly below CoI < 0.3. Comparing the RVS peak to peak pressure 
gradient response with its mBT counterpart, there is no difference in overall general 
behavior. All four cases demonstrate similar behavior, with no discernable difference 
among four cases that have a wide range of arch morphology.  
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Figure 5.12. Scatter plot of (a) peak to peak pressure gradient vs. CoI and (b) Spg 
against CoI for all four cases. 
 
The SVP requirements vary with aortic morphology and physiology 
associated with each patient. However, there is not sufficient evidence that can be 
drawn from the results supporting the hypothesis that aortic arch morphology affects 
hemodynamics responses in the RVS circulation with increasing coarctation severity.  
This is the first in vitro study to compare the hemodynamics of the RVS and 
mBT shunt circulations in the COA context. This study confirmed some clinical 
observations and hypotheses made in previous in silico and in vivo studies. Shimizu et 
al. together with Dr. Shunji Sano conducted a 0D simulation study comparing mBT 
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and RVS in 2011. One important observation they made, which is consistent with 
clinical observation, is that RVS is associated with lower ventricular power. Table 5.2 
illustrates part of their results. This can be attributed to fact that with mBT shunt, 
single ventricle has to pump blood to higher pressure system, that is, the systemic 
circulation (Shimizu, 2011). While with a RVS, pulmonary circulation can be 
pumped directly to PA, which has lower pressure than systemic circulation. This 
observation is also observed in this study.  
 
SW(mmHg ml) Mechanical efficiency (%) 
3.5-mm SPS 905 78.2 
6.0-mm non-valved RV-PA 827 84.7 
5.0-mm valved RV-PA 702 80.3 
Table 5.2. Influence of different shunt configuration on stroke works. SW: Stroke 
work (Shimizu, 2011).  
 
In addition, it has been reported repeatedly that due to diastolic run off in the 
RVS shunt, RVS can prevent pulmonary overcirculation and is usually associated 
with lower Qp/Qs (Shimizu S, 2011; Fischbach, 2013; Ohye, 2007). This phenomenon 
was also observed in this study, and differences in Qp/Qs are significant especially in 
study GOSH22 and UM10. Figure 5.13 illustrates Shimizu’s results. Figure 5.13 
illustrates Shimizu’s results, it can be seem that in 3.5 mm SPS case, due to the 
diastolic run-off from systemic to pulmonary circulation, yields Qp/Qs of 1.27. In the 
case of 5.0mm valved RV-PA shunt, there is no interaction between pulmonary and 
systemic circulation, yields Qp/Qs of 1.18. In 6.0mm non-valved RV-PA case, due to 
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pulmonary diastolic run off to RV, Qp is lowest thus yields the lowest Qp/Qs of 1.08. 
This is consistent with the observations that were made in this study.  
  
Figure 5.13. Hemodynamics obtained from the 3.5-mm systemic-to-pulmonary shunt 
(SPS) model, and 6.0-mm nonvalved and 5.0-mm valved right ventricle to pulmonary 




SUMMARY AND CONCLUSIONS  
An in vitro multi-scale, patient-specific Norwood circulation model was 
described and validated against clinical data. Using separate anatomically accurate 
phantoms of five patients having differing aortic morphologies following a Norwood 
procedure with BT shunt (mBT), the system was tuned to clinical patient-specific 
physiological parameters. Patient-specific conditions were achieved and pressure and 
flow rate were measured throughout the system and compared against clinical 
measurements. Results demonstrated that the time-based experimental measurements 
are physiological in form and statistical analysis shows that experimental time-based 
measurements are very similar to clinical measurements (0.72 < R2 < 0.95). These 
results showed good fidelity in replicating the mean values of the Norwood 
circulation at the patient-specific level (p > 0.10). In validation, the system was able 
to recapitulate the hemodynamics of different Norwood patients at the patient-specific 
level, and judged suitable to study the physiological and morphological differences at 
the local and systems-levels between patients and to study changes occurring over 
time within a patient.  
The validated MCS was applied to studies of coarctation effects in the 
Norwood with mBT circulation. Four patient-specific hemodynamic responses to 
neoaortic coarctation (NAO) variation were studied. A coarctation index was used as 
a measure of coarctation severity. CoI was changed between mild to severe to 
demonstrate the effect of NAO on hemodynamics. System level pressure and flow 
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rates responses were measured throughout the system. Overall, this study revealed 
that NAO caused increases in upper body flow (0.04 Lpm on average) and mBT 
shunt flow (0.05 Lpm on average), decreases in descending aorta flow (0.08 Lpm on 
average). NAO also caused hypertension in the aortic arch (7 mmHg increase on 
average) while hypotension in lower body (18.5 mmHg increase on average). NAO 
also increased SVP by 28.55 mW on average.  It was also concluded from sensitivity 
analysis that for all four cases, the single ventricle power (SVP), mean pressure 
difference and Qp/Qs increased noticeably only when CoI < 0.5. The results also 
indicated that CoI < 0.5 presents noticeable hemodynamic changes suggesting that 
surgical intervention should be considered. Differences in the single ventricle power 
(SVP) between patients of differing aortic morphology were observed with abnormal 
aortic arch morphology (dilated or tubular) associated with increased SVP. In 
summary, it was demonstrated that aortic morphology does affect hemodynamics, and 
NAO may not need immediate surgical intervention until reaching severe for patients. 
The mock circulatory system was modified to simulate the Norwood 
procedure with RVS. Four patient-specific hemodynamic responses to NAO variation 
were studied using this arrangement as direct comparison to the mBT shunt study. 
The RVS shunt flow occurred concurrently with ascending aortic flow while the mBT 
shunt flow showed a phase lag, between ascending aortic and shunt flow rate. The 
results showed that substituting the mBT with RVS can relieve pulmonary 
overcirculation in two of the cases (GOSH22, UM10), with average reverse to 
forward flow ratio of 39%, further causing Qp/Qs in those two cases to be closer to 
unity than the mBT scenario (by 0.7 on average). This behavior also contributed to 
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the reduction of total CO by 0.3 Lpm (four cases average compared with mBT 
scenarios) and brought down SVP requirements by 74.5 mW (four case average 
compared with mBT scenarios). In terms of sensitivity to CoI, the RVS cases 
mirrored the responses of the mBT cases in that no noticeable difference in SVP was 
noted until CoI < 0.6, whereby it increased significantly. Overall, the total changes of 
SVP in RVS with CoI in 3 out of 4 patients were slightly lower than those in mBT by 
5.8 mW (4 cases average). Differences in SVP required in the RVS cases were noted 
for the four different aortic arch morphologies studied. A tubular arch morphology 
was associated with a higher SVP than those with a dilated arch. Overall, the results 
showed that RVS eliminates the pulmonary overcirculation observed by mBT, and is 
associated with a lower SVP compared with mBT counterparts. RVS is slightly 
insensitive to NAO change compared with mBT counterparts (5.8 mW difference in 
SVP). 
 Limitations and Recommendations: 
Overall the results are satisfactory and some of the results presented in this 
dissertation confirmed the observations that were made in previous studies.  This 
dissertation furthers our understanding of the Sage 1 Norwood circulation due to its 
advantageous modelling method and patient-specific nature. However, there are a few 
limitations of the present study and future directions for continued studies.  
The study used rigid models of the aorta. A proximal compliance was used to 
allow realistic aortic pressure waveforms and excellent correlation with clinical 
waveforms was demonstrated. This also allows direct comparisons with numerical 
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models that use rigid test sections. However, a flexible model would enable accurate 
wall shear measurements and may offer other subtle benefits.  
The RVS study was conducted using a VAD rather than a real heart model. 
The difference between the VAD and a realistic heart model might affect the results. 
The VAD used in this study is not a realistic ventricle model, in a sense that it cannot 
simulate the contractility of a real ventricle physiologically. This discrepancy 
contributes to the fact that the reverse to forward flow ratio is higher in this study than 
clinical empirical data (39% vs. 25%). A realistic heart model would be beneficial in 
the future to further our understanding of RVS.  
This study did not attempt to measure velocity or wall shear within the 3D 
phantoms. To better understand why aortic arch morphology has an impact on 
hemodynamics, particle image velocimetry (PIV) should be used to measure the flow 
field in aortic arch. For example, while reverse flow in lower body flow rate was 
measured, the amounts going to the upper body versus to the mBT shunt were not 
measured. Future work can be conduct in this direction. 








In this appendix A, the uncertainty estimates for the results presented in this 
dissertation are discussed.  
 The error sources considered affecting the pressure and flow estimates 
included: zero-point systemic error, instrumental error, data acquisition error, and the 
random error found both within and between cardiac cycles. Propagation of elemental 
uncertainties to the uncertainty estimate is calculated by the Taylor expansion method 
(Figliola, 2014). In general elemental errors are propagated as: 
𝑢𝑟 = (∑ (𝜃 ∙ 𝑢𝑘)𝑘 )
1
2  (A.6) 
where 𝜃  is the sensitivity, uk is the elemental uncertainty and ur is the resultant 
uncertainty.  
Uncertainty in Pressure and Flow Rate Measurements: 
There are two types of contributing errors: systematic (mean offset from zero) 
and random (fluctuations due to noise about the mean set point) errors. Systemic error 
includes zero-point systemic error, instrumental error, and data acquisition error. The 
random error was found both within and between cardiac cycles.  
In the category of systemic error, zero-point errors indicate how well the 
instruments can be tuned to zero. Instrument errors were assigned as systematic 
uncertainty according to manufacturer’s manual statement of error. Data acquisition 
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errors were assigned based on the voltage range of the sensors and number of bits of 







  (A.7)  
where VR is the voltage range of the sensors and n is the number of bits of the DAQ 
board. 





  (A.8) 
where sx is the standard deviation, N is the number of samples, and 𝑆?̅? is the 
random standard error. In the case of estimating the uncertainty in a mean value 
extracted from many cycles, a data set of N mean values were used to compute a 
standard deviation from which a standard error was computed as per (2.8) Random 
error dominated, a random uncertainty was calculated 0.1 mmHg for pressure 
measurement and 0.01 Lpm for flow rate measurement .  
The elemental errors in pressure and flow rate measurements were considered 
to be independent (i.e., sensitivities set to equal 1) and uncorrelated and then 






 . Random uncertainty 
was propagated separately from systemic uncertainties. The final total uncertainty 
was propagated from the random uncertainty and the systemic uncertainty using the 
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root-sum-square method. The total uncertainty in the reported pressure and flow rate 
measurements are both under 3% at the 95% confidence level (critical t=2).  
For example, in the case of UM5 CO measurement, random uncertainty was 
found to be ±0.01 Lpm, zero-point uncertainty was assigned to be ±0.01 Lpm, 
instrument error was assigned to be ±0.008 Lpm (0.5% of the reading), data 
acquisition error was calculated to be ±0.003 Lpm. The propagated total uncertainty 
is ±0.02 Lpm. 
Similarly, for the case of UM 10 PAsc.Ao, random uncertainty was found to be 
±0.41mmHg, zero-point uncertainty was assigned to be ±0.1mmHg, instrument error 
was assigned to be ±0.365 mmHg (0.5% of the reading), data acquisition error was 
calculated to be ±0.004 mmHg. The propagated total uncertainty is ±0.56 mmHg. 
Table A1 below shows the sample uncertainty calculation details for two 
measurements assuming confidence level 95%. 








































Tabel A.1. Standard systematic uncertainties (b), and random uncertainty (s) and 95% 
confidence level uncertainties (u) for 2 examples.  
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The uncertainty in the reported pressure and flow rate measurements are both 
under 5% at the 95% confidence level in this dissertation.  
Uncertainty in Resistances and Compliances: 
 Uncertainty in resistance and in compliance are functions of pressure, flow rate, 
and dimensional measurements. With𝑅 =
∆𝑃
𝑄
, uncertainty in resistances can be estimated 
as:  
    𝑢𝑅 = √(
𝜕𝑅
𝜕𝑃





  (A.9) 
 With  𝐶 =
𝑉
𝑃 𝑎𝑏𝑠
 , contributing factors to compliance were identified as air volume 









  (A.10) 
 The uncertainty associated with resistances and compliances are reported in Table 
2.2.  
For the example of MUSC2 LBSVR, total uncertainty in lower body flow rate 
(uQ) was calculated to be ±0.02 Lpm, total uncertainty in ascending aortic pressure 
(uP) was calculated to be ±1.28 mmHg. Sensitivity term  
𝜕𝑅
𝜕𝑃




 was calculated to be 459.1 (mmHg/Lpm2). Total uncertainty in LBSVR 
was calculate to be 9.4 WU. 
Table A2 show the details in MUSC2 LBSVR uncertainty estimation. 
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459.1 0.02 3.0 1.28 9.4 
 
5.9% 
Tabel A2. Uncertainty propagation for MUSC2 LBSVR.  
As for compliance values, take the example of GOSH22 Cprox, total 
uncertainty in air volume (uV) was calculated to be ±0.0004 ml, total uncertainty in 




calculated to be 0.001235 (1/mmHg), 
𝜕𝐶
𝜕𝑃
 was calculated to be 0.0003 (ml/mmHg2). 
Total uncertainty in Cprox was calculate to be 0.02 ml/mmHg. Table A3 shows the 
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